Staphylococcus aureus (English Wikipedia)

Clinical trial number NCT01160172 for "A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults" at ClinicalTrials.gov
Clinical trial number NCT02388165 for "Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Posterior Instrumented Lumbar Spinal Fusion Procedure (STRIVE)" at ClinicalTrials.gov

dictionary.com

"Staphylococcus". Dictionary.com Unabridged (Online). n.d. "aureus". Dictionary.com Unabridged (Online). n.d.

doi.org

Masalha M, Borovok I, Schreiber R, Aharonowitz Y, Cohen G (December 2001). "Analysis of transcription of the Staphylococcus aureus aerobic class Ib and anaerobic class III ribonucleotide reductase genes in response to oxygen". Journal of Bacteriology. 183 (24): 7260–72. doi:10.1128/JB.183.24.7260-7272.2001. PMC 95576. PMID 11717286.
Kluytmans J, van Belkum A, Verbrugh H (July 1997). "Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks". Clinical Microbiology Reviews. 10 (3): 505–520. doi:10.1128/CMR.10.3.505. PMC 172932. PMID 9227864.
Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG (July 2015). "Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management". Clinical Microbiology Reviews. 28 (3): 603–661. doi:10.1128/CMR.00134-14. PMC 4451395. PMID 26016486.
Cole AM, Tahk S, Oren A, Yoshioka D, Kim YH, Park A, et al. (November 2001). "Determinants of Staphylococcus aureus nasal carriage". Clinical and Diagnostic Laboratory Immunology. 8 (6): 1064–9. doi:10.1128/CDLI.8.6.1064-1069.2001. PMC 96227. PMID 11687441.
Senok AC, Verstraelen H, Temmerman M, Botta GA (October 2009). "Probiotics for the treatment of bacterial vaginosis". The Cochrane Database of Systematic Reviews (4): CD006289. doi:10.1002/14651858.CD006289.pub2. PMID 19821358.
Schlecht LM, Peters BM, Krom BP, Freiberg JA, Hänsch GM, Filler SG, et al. (January 2015). "Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue". Microbiology. 161 (Pt 1): 168–181. doi:10.1099/mic.0.083485-0. PMC 4274785. PMID 25332378.
Fitzgerald JR, Sturdevant DE, Mackie SM, Gill SR, Musser JM (July 2001). "Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic". Proceedings of the National Academy of Sciences of the United States of America. 98 (15): 8821–6. Bibcode:2001PNAS...98.8821F. doi:10.1073/pnas.161098098. PMC 37519. PMID 11447287.
Lindsay JA (February 2010). "Genomic variation and evolution of Staphylococcus aureus". International Journal of Medical Microbiology. 300 (2–3): 98–103. doi:10.1016/j.ijmm.2009.08.013. PMID 19811948.
Fitzgerald JR (January 2014). "Evolution of Staphylococcus aureus during human colonization and infection". Infection, Genetics and Evolution. 21: 542–7. Bibcode:2014InfGE..21..542F. doi:10.1016/j.meegid.2013.04.020. PMID 23624187.
van Belkum A, Melles DC, Nouwen J, van Leeuwen WB, van Wamel W, Vos MC, et al. (January 2009). "Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus". Infection, Genetics and Evolution. 9 (1): 32–47. Bibcode:2009InfGE...9...32V. doi:10.1016/j.meegid.2008.09.012. PMID 19000784.
Varrone JJ, de Mesy Bentley KL, Bello-Irizarry SN, Nishitani K, Mack S, Hunter JG, et al. (October 2014). "Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters". Journal of Orthopaedic Research. 32 (10): 1389–96. doi:10.1002/jor.22672. PMC 4234088. PMID 24992290.
Matthews KR, Roberson J, Gillespie BE, Luther DA, Oliver SP (June 1997). "Identification and Differentiation of Coagulase-Negative Staphylococcus aureus by Polymerase Chain Reaction". Journal of Food Protection. 60 (6): 686–8. doi:10.4315/0362-028X-60.6.686. PMID 31195568.
Morikawa K, Takemura AJ, Inose Y, Tsai M, Nguyen TL, Ohta T, et al. (2012). "Expression of a cryptic secondary sigma factor gene unveils natural competence for DNA transformation in Staphylococcus aureus". PLOS Pathogens. 8 (11): e1003003. doi:10.1371/journal.ppat.1003003. PMC 3486894. PMID 23133387.
Fagerlund A, Granum PE, Håvarstein LS (November 2014). "Staphylococcus aureus competence genes: mapping of the SigH, ComK1 and ComK2 regulons by transcriptome sequencing". Molecular Microbiology. 94 (3): 557–579. doi:10.1111/mmi.12767. PMID 25155269. S2CID 1568023.
Schenck LP, Surette MG, Bowdish DM (November 2016). "Composition and immunological significance of the upper respiratory tract microbiota". FEBS Letters. 590 (21): 3705–20. doi:10.1002/1873-3468.12455. PMC 7164007. PMID 27730630.
Wollina U (2017). "Microbiome in atopic dermatitis". Clinical, Cosmetic and Investigational Dermatology. 10: 51–56. doi:10.2147/CCID.S130013. PMC 5327846. PMID 28260936.
Otto M (April 2010). "Staphylococcus colonization of the skin and antimicrobial peptides". Expert Review of Dermatology. 5 (2): 183–195. doi:10.1586/edm.10.6. PMC 2867359. PMID 20473345.
Roberts RR, Hota B, Ahmad I, Scott R. Douglas, II, Foster SD, Abbasi F, et al. (15 October 2009). "Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship". Clinical Infectious Diseases. 49 (8): 1175–1184. doi:10.1086/605630. ISSN 1058-4838. PMID 19739972.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. (17 October 2007). "Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States". JAMA. 298 (15): 1763–1771. doi:10.1001/jama.298.15.1763. ISSN 0098-7484. PMID 17940231.
Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. (9 December 2013). "Health Care–Associated Infections: A Meta-analysis of Costs and Financial Impact on the US Health Care System". JAMA Internal Medicine. 173 (22): 2039–2046. doi:10.1001/jamainternmed.2013.9763. ISSN 2168-6106. PMID 23999949.
Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. (May 2010). "Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)". Infection Control & Hospital Epidemiology. 31 (5): 431–455. doi:10.1086/651706. ISSN 0899-823X. PMID 20307191.
Kourtis AP (2019). "Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States". MMWR. Morbidity and Mortality Weekly Report. 68 (9): 214–219. doi:10.15585/mmwr.mm6809e1. ISSN 0149-2195. PMC 6421967. PMID 30845118.
Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (1 January 2003). "Comparison of Mortality Associated with Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Meta-analysis". Clinical Infectious Diseases. 36 (1): 53–59. doi:10.1086/345476. ISSN 1058-4838.
Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, et al. (25 November 2013). "National Burden of Invasive Methicillin-Resistant Staphylococcus aureus Infections, United States, 2011". JAMA Internal Medicine. 173 (21): 1970–1978. doi:10.1001/jamainternmed.2013.10423. ISSN 2168-6106. PMC 10887428. PMID 24043270.
Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, Jernigan DB (June 2005). "Methicillin-resistant-Staphylococcus aureus hospitalizations, United States". Emerging Infectious Diseases. 11 (6): 868–872. doi:10.3201/eid1106.040831. PMC 3367609. PMID 15963281.
Kavanaugh JS, Horswill AR (June 2016). "Impact of Environmental Cues on Staphylococcal Quorum Sensing and Biofilm Development". The Journal of Biological Chemistry (Review). 291 (24): 12556–64. doi:10.1074/jbc.R116.722710. PMC 4933443. PMID 27129223.
Monnot GC, Wegrecki M, Cheng TY, Chen YL, Sallee BN, Chakravarthy R, et al. (January 2023). "Staphylococcal phosphatidylglycerol antigens activate human T cells via CD1a". Nature Immunology. 24 (1): 110–122. doi:10.1038/s41590-022-01375-z. PMC 10389259. PMID 35265979. S2CID 255039948.
Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH, et al. (April 2015). "Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis". Immunity. 42 (4): 756–766. doi:10.1016/j.immuni.2015.03.014. PMC 4407815. PMID 25902485.
Nakatsuji T, Chen TH, Two AM, Chun KA, Narala S, Geha RS, et al. (November 2016). "Staphylococcus aureus Exploits Epidermal Barrier Defects in Atopic Dermatitis to Trigger Cytokine Expression". The Journal of Investigative Dermatology. 136 (11): 2192–2200. doi:10.1016/j.jid.2016.05.127. PMC 5103312. PMID 27381887.
Curran JP, Al-Salihi FL (August 1980). "Neonatal staphylococcal scalded skin syndrome: massive outbreak due to an unusual phage type". Pediatrics. 66 (2): 285–290. doi:10.1542/peds.66.2.285. PMID 6447271. S2CID 21783186.
Gallo RL, Horswill AR (May 2024). "Staphylococcus aureus: The Bug Behind the Itch in Atopic Dermatitis". Journal of Investigative Dermatology. 144 (5): 950–953. doi:10.1016/j.jid.2024.01.001. PMID 38430083.
George SM, Karanovic S, Harrison DA, Rani A, Birnie AJ, Bath-Hextall FJ, et al. (October 2019). "Interventions to reduce Staphylococcus aureus in the management of eczema". The Cochrane Database of Systematic Reviews. 2019 (10). doi:10.1002/14651858.CD003871.pub3. PMC 6818407. PMID 31684694.
Eczema in children: uncertainties addressed (Report). NIHR Evidence. 19 March 2024. doi:10.3310/nihrevidence_62438.
Rasmussen RV, Fowler VG, Skov R, Bruun NE (January 2011). "Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA". Future Microbiology. 6 (1): 43–56. doi:10.2217/fmb.10.155. PMC 3031962. PMID 21162635.
Latha T, Anil B, Manjunatha H, Chiranjay M, Elsa D, Baby N, et al. (March 2019). "MRSA: the leading pathogen of orthopedic infection in a tertiary care hospital, South India". Afr Health Sci. 19 (1): 1393–1401. doi:10.4314/ahs.v19i1.12. PMC 6531934. PMID 31148966.
Zago CE, Silva S, Sanitá PV, Barbugli PA, Dias CM, Lordello VB, et al. (2015). "Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA)". PLOS ONE. 10 (4): e0123206. Bibcode:2015PLoSO..1023206Z. doi:10.1371/journal.pone.0123206. PMC 4395328. PMID 25875834.
Nandakumar V, Chittaranjan S, Kurian VM, Doble M (2013). "Characteristics of bacterial biofilm associated with implant material in clinical practice". Polymer Journal. 45 (2): 137–152. doi:10.1038/pj.2012.130.
Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME (1 September 2011). "Staphylococcus aureus biofilms: properties, regulation, and roles in human disease". Virulence. 2 (5): 445–459. doi:10.4161/viru.2.5.17724. PMC 3322633. PMID 21921685.
Chung PY, Toh YS (April 2014). "Anti-biofilm agents: recent breakthrough against multi-drug resistant Staphylococcus aureus". Pathogens and Disease. 70 (3): 231–9. doi:10.1111/2049-632x.12141. PMID 24453168.
Hogan S, Zapotoczna M, Stevens NT, Humphreys H, O'Gara JP, O'Neill E (June 2017). "Potential use of targeted enzymatic agents in the treatment of Staphylococcus aureus biofilm-related infections". The Journal of Hospital Infection. 96 (2): 177–182. doi:10.1016/j.jhin.2017.02.008. PMID 28351512.
Boost MV, O'Donoghue MM, James A (July 2008). "Prevalence of Staphylococcus aureus carriage among dogs and their owners". Epidemiology and Infection. 136 (7): 953–964. doi:10.1017/S0950268807009326. PMC 2870875. PMID 17678561.
Boost MV, O'Donoghue MM, James A (July 2008). "Prevalence of Staphylococcus aureus carriage among dogs and their owners". Epidemiology and Infection. 136 (7): 953–964. doi:10.1017/s0950268807009326. hdl:10397/7558. PMC 2870875. PMID 17678561.
Cenci-Goga BT, Karama M, Rossitto PV, Morgante RA, Cullor JS (September 2003). "Enterotoxin production by Staphylococcus aureus isolated from mastitic cows" (PDF). Journal of Food Protection. 66 (9): 1693–6. doi:10.4315/0362-028X-66.9.1693. PMID 14503727.
Cheung GY, Bae JS, Otto M (December 2021). "Pathogenicity and virulence of Staphylococcus aureus". Virulence. 12 (1): 547–569. doi:10.1080/21505594.2021.1878688. PMC 7872022. PMID 33522395.
Berends ET, Horswill AR, Haste NM, Monestier M, Nizet V, von Köckritz-Blickwede M (2010). "Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps". Journal of Innate Immunity. 2 (6): 576–586. doi:10.1159/000319909. PMC 2982853. PMID 20829609.
Monteith AJ, Miller JM, Maxwell CN, Chazin WJ, Skaar EP (September 2021). "Neutrophil extracellular traps enhance macrophage killing of bacterial pathogens". Science Advances. 7 (37): eabj2101. Bibcode:2021SciA....7.2101M. doi:10.1126/sciadv.abj2101. PMC 8442908. PMID 34516771.
Dinges MM, Orwin PM, Schlievert PM (January 2000). "Exotoxins of Staphylococcus aureus". Clinical Microbiology Reviews. 13 (1): 16–34, table of contents. doi:10.1128/cmr.13.1.16. PMC 88931. PMID 10627489.
Etter D, Schelin J, Schuppler M, Johler S (September 2020). "Staphylococcal Enterotoxin C-An Update on SEC Variants, Their Structure and Properties, and Their Role in Foodborne Intoxications". Toxins. 12 (9): 584. doi:10.3390/toxins12090584. PMC 7551944. PMID 32927913.
Jarraud S, Peyrat MA, Lim A, Tristan A, Bes M, Mougel C, et al. (January 2001). "egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus". Journal of Immunology. 166 (1): 669–677. doi:10.4049/jimmunol.166.1.669. PMID 11123352.
Becker K, Friedrich AW, Lubritz G, Weilert M, Peters G, Von Eiff C (April 2003). "Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens". Journal of Clinical Microbiology. 41 (4): 1434–9. doi:10.1128/jcm.41.4.1434-1439.2003. PMC 153929. PMID 12682126.
Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. (November 1999). "Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia". Clinical Infectious Diseases. 29 (5): 1128–32. doi:10.1086/313461. PMID 10524952.
Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. (March 2002). "Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients". Lancet. 359 (9308): 753–9. doi:10.1016/S0140-6736(02)07877-7. PMID 11888586. S2CID 20400336. As PDF Archived 14 July 2014 at the Wayback Machine
Bowman L, Palmer T (October 2021). "The Type VII Secretion System of Staphylococcus". Annual Review of Microbiology. 75 (1): 471–494. doi:10.1146/annurev-micro-012721-123600. PMID 34343022. S2CID 236915377.
Cao Z, Casabona MG, Kneuper H, Chalmers JD, Palmer T (October 2016). "The type VII secretion system of Staphylococcus aureus secretes a nuclease toxin that targets competitor bacteria". Nature Microbiology. 2 (1): 16183. doi:10.1038/nmicrobiol.2016.183. PMC 5325307. PMID 27723728.
Ulhuq FR, Gomes MC, Duggan GM, Guo M, Mendonca C, Buchanan G, et al. (August 2020). "A membrane-depolarizing toxin substrate of the Staphylococcus aureus type VII secretion system mediates intraspecies competition". Proceedings of the National Academy of Sciences of the United States of America. 117 (34): 20836–47. Bibcode:2020PNAS..11720836U. doi:10.1073/pnas.2006110117. PMC 7456083. PMID 32769205.
Burts ML, Williams WA, DeBord K, Missiakas DM (January 2005). "EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections". Proceedings of the National Academy of Sciences of the United States of America. 102 (4): 1169–74. Bibcode:2005PNAS..102.1169B. doi:10.1073/pnas.0405620102. PMC 545836. PMID 15657139.
Dai Y, Wang Y, Liu Q, Gao Q, Lu H, Meng H, et al. (5 May 2017). "A Novel ESAT-6 Secretion System-Secreted Protein EsxX of Community-Associated Staphylococcus aureus Lineage ST398 Contributes to Immune Evasion and Virulence". Frontiers in Microbiology. 8: 819. doi:10.3389/fmicb.2017.00819. PMC 5418362. PMID 28529509.
Kim S, Reyes D, Beaume M, Francois P, Cheung A (October 2014). "Contribution of teg49 small RNA in the 5' upstream transcriptional region of sarA to virulence in Staphylococcus aureus". Infection and Immunity. 82 (10): 4369–79. doi:10.1128/iai.02002-14. PMC 4187880. PMID 25092913.
Chevalier C, Boisset S, Romilly C, Masquida B, Fechter P, Geissmann T, et al. (March 2010). "Staphylococcus aureus RNAIII binds to two distant regions of coa mRNA to arrest translation and promote mRNA degradation". PLOS Pathogens. 6 (3): e1000809. doi:10.1371/journal.ppat.1000809. PMC 2837412. PMID 20300607.
Chabelskaya S, Gaillot O, Felden B (June 2010). "A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule". PLOS Pathogens. 6 (6): e1000927. doi:10.1371/journal.ppat.1000927. PMC 2880579. PMID 20532214.
Le Pabic H, Germain-Amiot N, Bordeau V, Felden B (October 2015). "A bacterial regulatory RNA attenuates virulence, spread and human host cell phagocytosis". Nucleic Acids Research. 43 (19): 9232–48. doi:10.1093/nar/gkv783. PMC 4627067. PMID 26240382.
Mauro T, Rouillon A, Felden B (December 2016). "Insights into the regulation of small RNA expression: SarA represses the expression of two sRNAs in Staphylococcus aureus". Nucleic Acids Research. 44 (21): 10186–200. doi:10.1093/nar/gkw777. PMC 5137438. PMID 27596601.
Bohn C, Rigoulay C, Chabelskaya S, Sharma CM, Marchais A, Skorski P, et al. (October 2010). "Experimental discovery of small RNAs in Staphylococcus aureus reveals a riboregulator of central metabolism". Nucleic Acids Research. 38 (19): 6620–36. doi:10.1093/nar/gkq462. PMC 2965222. PMID 20511587.
Sayed N, Jousselin A, Felden B (December 2011). "A cis-antisense RNA acts in trans in Staphylococcus aureus to control translation of a human cytolytic peptide" (PDF). Nature Structural & Molecular Biology. 19 (1): 105–112. doi:10.1038/nsmb.2193. PMID 22198463. S2CID 8217681.
Morrison JM, Miller EW, Benson MA, Alonzo F, Yoong P, Torres VJ, et al. (June 2012). "Characterization of SSR42, a novel virulence factor regulatory RNA that contributes to the pathogenesis of a Staphylococcus aureus USA300 representative". Journal of Bacteriology. 194 (11): 2924–38. doi:10.1128/JB.06708-11. PMC 3370614. PMID 22493015.
Xue T, Zhang X, Sun H, Sun B (February 2014). "ArtR, a novel sRNA of Staphylococcus aureus, regulates α-toxin expression by targeting the 5' UTR of sarT mRNA". Medical Microbiology and Immunology. 203 (1): 1–12. doi:10.1007/s00430-013-0307-0. PMID 23955428. S2CID 18371872.
Coronel-Tellez RH, Pospiech M, Barrault M, Liu W, Bordeau V, Vasnier C, et al. (August 2022). "sRNA-controlled iron sparing response in Staphylococci". Nucleic Acids Research. 50 (15): 8529–8546. doi:10.1093/nar/gkac648. PMC 9410917. PMID 35904807.
Ha KP, Clarke RS, Kim GL, Brittan JL, Rowley JE, Mavridou DA, et al. (November 2020). "Staphylococcal DNA Repair Is Required for Infection". mBio. 11 (6): e02288-20. doi:10.1128/mBio.02288-20. PMC 7683395. PMID 33203752.
Ruiz de los Mozos I, Vergara-Irigaray M, Segura V, Villanueva M, Bitarte N, Saramago M, et al. (2013). "Base pairing interaction between 5'- and 3'-UTRs controls icaR mRNA translation in Staphylococcus aureus". PLOS Genetics. 9 (12): e1004001. doi:10.1371/journal.pgen.1004001. PMC 3868564. PMID 24367275.
Arciola CR, Campoccia D, Speziale P, Montanaro L, Costerton JW (September 2012). "Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials". Biomaterials. 33 (26): 5967–82. doi:10.1016/j.biomaterials.2012.05.031. PMID 22695065.
de la Fuente-Núñez C, Reffuveille F, Fernández L, Hancock RE (October 2013). "Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies". Current Opinion in Microbiology. 16 (5): 580–9. doi:10.1016/j.mib.2013.06.013. PMID 23880136.
McLaughlin RA, Hoogewerf AJ (August 2006). "Interleukin-1beta-induced growth enhancement of Staphylococcus aureus occurs in biofilm but not planktonic cultures". Microbial Pathogenesis. 41 (2–3): 67–79. doi:10.1016/j.micpath.2006.04.005. PMID 16769197.
Nassar R, Hachim M, Nassar M, Kaklamanos EG, Jamal M, Williams D, et al. (2021). "Microbial Metabolic Genes Crucial for S. aureus Biofilms: An Insight From Re-analysis of Publicly Available Microarray Datasets". Frontiers in Microbiology. 11: 607002. doi:10.3389/fmicb.2020.607002. PMC 7876462. PMID 33584569.
Schneewind O, Fowler A, Faull KF (April 1995). "Structure of the cell wall anchor of surface proteins in Staphylococcus aureus". Science. 268 (5207): 103–6. Bibcode:1995Sci...268..103S. doi:10.1126/science.7701329. PMID 7701329.
Patel AH, Nowlan P, Weavers ED, Foster T (December 1987). "Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement". Infection and Immunity. 55 (12): 3103–10. doi:10.1128/IAI.55.12.3103-3110.1987. PMC 260034. PMID 3679545.
Zhu J, Lu C, Standland M, Lai E, Moreno GN, Umeda A, et al. (February 2008). "Single mutation on the surface of Staphylococcus aureus Sortase A can disrupt its dimerization". Biochemistry. 47 (6): 1667–74. doi:10.1021/bi7014597. PMID 18193895.
Clauditz A, Resch A, Wieland KP, Peschel A, Götz F (August 2006). "Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress". Infection and Immunity. 74 (8): 4950–3. doi:10.1128/IAI.00204-06. PMC 1539600. PMID 16861688.
Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, et al. (July 2005). "Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity". The Journal of Experimental Medicine. 202 (2): 209–215. doi:10.1084/jem.20050846. PMC 2213009. PMID 16009720.
Liu CI, Liu GY, Song Y, Yin F, Hensler ME, Jeng WY, et al. (March 2008). "A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence". Science. 319 (5868): 1391–4. Bibcode:2008Sci...319.1391L. doi:10.1126/science.1153018. PMC 2747771. PMID 18276850.
Barrett TJ, Hawkins CL (2012). "Hypothiocyanous Acid: Benign or Deadly?". Chemical Research in Toxicology. 25 (2): 263–273. doi:10.1021/tx200219s. PMID 22053976.
Loi VV, Busche T, Schnaufer F, Kalinowski J, Antelmann H (2023). "The neutrophil oxidant hypothiocyanous acid causes a thiol-specific stress response and an oxidative shift of the bacillithiol redox potential in Staphylococcus aureus". Microbiology Spectrum. 11 (6): e03252-23. doi:10.1128/spectrum.03252-23. PMC 10715087. PMID 37930020.
Shearer HL, Loi VV, Weiland P, Bange G, Altegoer F, Hampton MB, et al. (2023). "MerA functions as a hypothiocyanous acid reductase and defense mechanism in Staphylococcus aureus". Molecular Microbiology. 119 (4): 456–470. doi:10.1111/MMI.15035. PMID 36779383.
Shearer HL, Pace PE, Paton JC, Hampton MB, Dickerhof N (2022). "A newly identified flavoprotein disulfide reductase Har protects Streptococcus pneumoniae against hypothiocyanous acid". Journal of Biological Chemistry. 298 (9): 102359. doi:10.1016/J.JBC.2022.102359. PMC 9483559. PMID 35952759.
Deurenberg RH, Stobberingh EE (December 2008). "The evolution of Staphylococcus aureus". Infection, Genetics and Evolution. 8 (6): 747–763. Bibcode:2008InfGE...8..747D. doi:10.1016/j.meegid.2008.07.007. PMID 18718557.
Aires de Sousa M, Conceição T, Simas C, de Lencastre H (October 2005). "Comparison of genetic backgrounds of methicillin-resistant and -susceptible Staphylococcus aureus isolates from Portuguese hospitals and the community". Journal of Clinical Microbiology. 43 (10): 5150–7. doi:10.1128/JCM.43.10.5150-5157.2005. PMC 1248511. PMID 16207977.
Kim J (2009). "Understanding the Evolution of Methicillin-Resistant Staphylococcus aureus". Clinical Microbiology Newsletter. 31 (3): 17–23. doi:10.1016/j.clinmicnews.2009.01.002.
Korzeniowski O, Sande MA (October 1982). "Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study". Annals of Internal Medicine. 97 (4): 496–503. doi:10.7326/0003-4819-97-4-496. PMID 6751182.
Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, et al. (1998). "Diagnosis and management of infective endocarditis and its complications". Circulation. 98 (25): 2936–48. doi:10.1161/01.CIR.98.25.2936. PMID 9860802.
Cosgrove SE, Vigliani GA, Fowler VG, Abrutyn E, Corey GR, Levine DP, et al. (March 2009). "Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic". Clinical Infectious Diseases. 48 (6): 713–721. doi:10.1086/597031. PMID 19207079.
Thwaites GE, Scarborough M, Szubert A, Nsutebu E, Tilley R, Greig J, et al. (February 2018). "Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial". Lancet. 391 (10121): 668–678. doi:10.1016/S0140-6736(17)32456-X. PMC 5820409. PMID 29249276.
Chambers HF (2001). "The changing epidemiology of Staphylococcus aureus?". Emerging Infectious Diseases. 7 (2): 178–182. doi:10.3201/eid0702.010204. PMC 2631711. PMID 11294701.
Bonomo RA, Van Zile PS, Li Q, Shermock KM, McCormick WG, Kohut B (October 2007). "Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspective". Expert Review of Anti-Infective Therapy. 5 (5): 773–782. doi:10.1586/14787210.5.5.773. PMID 17914912. S2CID 31594289.
Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. (Antimicrobial Resistance Collaborators) (February 2022). "Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis". Lancet. 399 (10325): 629–655. doi:10.1016/S0140-6736(21)02724-0. PMC 8841637. PMID 35065702.
Korotetskiy IS, Shilov SV, Kuznetsova TV, Zubenko N, Ivanova L, Reva ON (2025). "Epigenetic background of lineage-specific gene expression landscapes of four Staphylococcus aureus hospital isolates". PLOS ONE. 20 (5): e0322006. Bibcode:2025PLoSO..2022006K. doi:10.1371/journal.pone.0322006. PMC 12052166. PMID 40323905.
Jamrozy D, Coll F, Mather AE, Harris SR, Harrison EM, MacGowan A, et al. (September 2017). "Evolution of mobile genetic element composition in an epidemic methicillin-resistant Staphylococcus aureus: temporal changes correlated with frequent loss and gain events". BMC Genomics. 18 (1): 684. doi:10.1186/s12864-017-4065-z. PMC 5584012. PMID 28870171.
Pozzi C, Waters EM, Rudkin JK, Schaeffer CR, Lohan AJ, Tong P, et al. (5 April 2012). Sullam PM (ed.). "Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections". PLOS Pathogens. 8 (4): e1002626. doi:10.1371/journal.ppat.1002626. PMC 3320603. PMID 22496652.
Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V (September 2000). "Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics". Nature. 407 (6802): 340–8. Bibcode:2000Natur.407..340C. doi:10.1038/35030019. PMID 11014183. S2CID 4408938.
Sakon J, Liao HH, Kanikula AM, Benning MM, Rayment I, Holden HM (November 1993). "Molecular structure of kanamycin nucleotidyltransferase determined to 3.0-A resolution". Biochemistry. 32 (45): 11977–84. doi:10.1021/bi00096a006. PMID 8218273.
Arthur M, Courvalin P (August 1993). "Genetics and mechanisms of glycopeptide resistance in enterococci". Antimicrobial Agents and Chemotherapy. 37 (8). ASM: 1563–71. doi:10.1128/AAC.37.8.1563. PMC 188020. PMID 8215264.
Rolinson GN, Stevens S, Batchelor FR, Wood JC, Chain EB (September 1960). "Bacteriological studies on a new penicillin-BRL. 1241". Lancet. 2 (7150): 564–7. doi:10.1136/bmj.1.5219.124-a. PMC 1952878. PMID 14438510.
Johnson AP, Aucken HM, Cavendish S, Ganner M, Wale MC, Warner M, et al. (July 2001). "Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS)". The Journal of Antimicrobial Chemotherapy. 48 (1): 143–4. doi:10.1093/jac/48.1.143. PMID 11418528.
Chen CJ, Huang YC (August 2018). "Emergence of livestock-associated methicillin-resistant Staphylococcus aureus: Should it be a concern?". Journal of the Formosan Medical Association = Taiwan Yi Zhi. 117 (8): 658–661. doi:10.1016/j.jfma.2018.04.004. PMID 29754805. S2CID 21659477.
^{[verification needed]}Blot SI, Vandewoude KH, Hoste EA, Colardyn FA (October 2002). "Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus". Archives of Internal Medicine. 162 (19): 2229–35. doi:10.1001/archinte.162.19.2229. PMID 12390067.
Pader V, Hakim S, Painter KL, Wigneshweraraj S, Clarke TB, Edwards AM (24 October 2016). "Staphylococcus aureus inactivates daptomycin by releasing membrane phospholipids". Nature Microbiology. 2 (1): 16194. doi:10.1038/nmicrobiol.2016.194. hdl:10044/1/40119. ISSN 2058-5276. PMID 27775684.
Yang SJ, Bayer AS, Mishra NN, Meehl M, Ledala N, Yeaman MR, et al. (22 December 2012). "The Staphylococcus aureus Two-Component Regulatory System, GraRS, Senses and Confers Resistance to Selected Cationic Antimicrobial Peptides". Infection and Immunity. 80 (1): 74–81. doi:10.1128/iai.05669-11. PMC 3255649. PMID 21986630.
Ledger EV, Mesnage S, Edwards AM (19 April 2022). "Human serum triggers antibiotic tolerance in Staphylococcus aureus". Nature Communications. 13 (1): 2041. Bibcode:2022NatCo..13.2041L. doi:10.1038/s41467-022-29717-3. ISSN 2041-1723. PMC 9018823. PMID 35440121.
Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (July 1997). "Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility". The Journal of Antimicrobial Chemotherapy. 40 (1): 135–6. doi:10.1093/jac/40.1.135. PMID 9249217.
Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. (April 2003). "Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene". The New England Journal of Medicine. 348 (14): 1342–7. doi:10.1056/NEJMoa025025. PMID 12672861.
Menichetti F (May 2005). "Current and emerging serious Gram-positive infections". Clinical Microbiology and Infection. 11 (Suppl 3): 22–28. doi:10.1111/j.1469-0691.2005.01138.x. PMID 15811021.
Sengupta M, Jain V, Wilkinson BJ, Jayaswal RK (June 2012). "Chromatin immunoprecipitation identifies genes under direct VraSR regulation in Staphylococcus aureus". Canadian Journal of Microbiology. 58 (6): 703–8. doi:10.1139/w2012-043. PMID 22571705.
Holasová K, Křížkovská B, Hoang L, Dobiasová S, Lipov J, Macek T, et al. (May 2022). "Flavonolignans from silymarin modulate antibiotic resistance and virulence in Staphylococcus aureus". Biomedicine & Pharmacotherapy. 149: 112806. doi:10.1016/j.biopha.2022.112806. PMID 35303568.
Latha T, Bhat, Hande M, Mukhopadyay C, Devi ES, Nayak B (2018). "Methicillin-resistant staphylococcus aureus carriage among health-care professionals of a tertiary care hospital". Asian J Pharm Clin Res. 11 (3): 346–9. doi:10.22159/ajpcr.2018.v11i3.23151.
Campos A, Arias A, Betancor L, Rodríguez C, Hernández AM, López Aguado D, et al. (July 1998). "Study of common aerobic flora of human cerumen". The Journal of Laryngology and Otology. 112 (7): 613–6. doi:10.1017/s002221510014126x. PMID 9775288. S2CID 29362695.
Quinn GA, Cole AM (September 2007). "Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium". Immunology. 122 (1): 80–89. doi:10.1111/j.1365-2567.2007.02615.x. PMC 2265977. PMID 17472720.
Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. (December 2005). "The role of nasal carriage in Staphylococcus aureus infections". The Lancet. Infectious Diseases. 5 (12): 751–762. doi:10.1016/S1473-3099(05)70295-4. PMID 16310147.
Munir MT, Pailhories H, Eveillard M, Irle M, Aviat F, Federighi M, et al. (August 2020). "Experimental Parameters Influence the Observed Antimicrobial Response of Oak Wood (Quercus petraea)". Antibiotics. 9 (9): 535. doi:10.3390/antibiotics9090535. PMC 7558063. PMID 32847132.
Neely AN, Maley MP (February 2000). "Survival of enterococci and staphylococci on hospital fabrics and plastic". Journal of Clinical Microbiology. 38 (2): 724–6. doi:10.1128/JCM.38.2.724-726.2000. PMC 86187. PMID 10655374.
Cook HA, Furuya EY, Larson E, Vasquez G, Lowy FD (February 2007). "Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus". Clinical Infectious Diseases. 44 (3): 410–3. doi:10.1086/510681. PMID 17205449.
Wu X, Su YC (August 2014). "Effects of frozen storage on survival of Staphylococcus aureus and enterotoxin production in precooked tuna meat". Journal of Food Science. 79 (8): M1554 – M1559. doi:10.1111/1750-3841.12530. PMID 25039601.
Bolton KJ, Dodd CE, Mead GC, Waites WM (1988). "Chlorine resistance of strains of Staphylococcus aureus isolated from poultry processing plants". Letters in Applied Microbiology. 6 (2): 31–34. doi:10.1111/j.1472-765X.1988.tb01208.x. S2CID 84137649.
Mead GC, Adams BW (1986). "Chlorine resistance of Staphylococcus aureus isolated from turkeys and turkey products". Letters in Applied Microbiology. 3 (6): 131–3. doi:10.1111/j.1472-765X.1986.tb01566.x. S2CID 86676949.
van Rijen M, Bonten M, Wenzel R, Kluytmans J, et al. (Cochrane Wounds Group) (October 2008). "Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers". The Cochrane Database of Systematic Reviews. 2011 (4): CD006216. doi:10.1002/14651858.CD006216.pub2. PMC 8988859. PMID 18843708.
Liu Z, Norman G, Iheozor-Ejiofor Z, Wong JK, Crosbie EJ, Wilson P, et al. (Cochrane Wounds Group) (May 2017). "Nasal decontamination for the prevention of surgical site infection in Staphylococcus aureus carriers". The Cochrane Database of Systematic Reviews. 5 (8): CD012462. doi:10.1002/14651858.CD012462.pub2. PMC 6481881. PMID 28516472.
Begier E, Seiden DJ, Patton M, Zito E, Severs J, Cooper D, et al. (February 2017). "SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies". Vaccine. 35 (8): 1132–9. doi:10.1016/j.vaccine.2017.01.024. PMID 28143674.
Torre A, Bacconi M, Sammicheli C, Galletti B, Laera D, Fontana MR, et al. (August 2015). "Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice". Infection and Immunity. 83 (8): 3157–63. doi:10.1128/IAI.00258-15. PMC 4496606. PMID 26015481.
Scheper H, Wubbolts JM, Verhagen JA, de Visser AW, van der Wal RJ, Visser LG, et al. (29 January 2021). "SAAP-148 Eradicates MRSA Persisters Within Mature Biofilm Models Simulating Prosthetic Joint Infection". Frontiers in Microbiology. 12: 625952. doi:10.3389/fmicb.2021.625952. PMC 7879538. PMID 33584628.
van den Biggelaar RH, Walburg KV, van den Eeden SJ, van Doorn CL, Meiler E, de Ries AS, et al. (2024). "Identification of kinase modulators as host-directed therapeutics against intracellular methicillin-resistant Staphylococcus aureus". Frontiers in Cellular and Infection Microbiology. 14: 1367938. doi:10.3389/fcimb.2024.1367938. PMC 10999543. PMID 38590439.
Mayr-Harting A (August 1955). "The acquisition of penicillin resistance by Staphylococcus aureus, strain Oxford". Journal of General Microbiology. 13 (1): 9–21. doi:10.1099/00221287-13-1-9. PMID 13252206.
Kearns AM, Ganner M, Holmes A (August 2006). "The 'Oxford Staphylococcus': a note of caution". The Journal of Antimicrobial Chemotherapy. 58 (2): 480–1. doi:10.1093/jac/dkl230. PMID 16735421.

eucast.org

EUCAST (1 January 2020). Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST: version 10.0. Växjö, Sweden: European Society of Clinical Microbiology and Infectious Diseases. p. 9.

food.gov.uk

"Food standard agency".

foodsafety.gov

"Staphylococcus." Foodsafety.gov, U.S. Department of Health and Human Services, https://www.foodsafety.gov/poisoning/causes/bacteriaviruses/staphylococcus/.

formatex.info

"Strengthening the immune system as an antimicrobial strategy against Staphylococcus aureus infections" (PDF). FORMATEX RESEARCH CENTER. 11 December 2013. Archived (PDF) from the original on 22 November 2015. Retrieved 7 October 2015.

globenewswire.com

"Nabi Biopharmaceuticals Completes Final PentaStaph(TM) Milestone" (Press release). GLOBE NEWSWIRE. 27 April 2011. Retrieved 7 October 2015.

handle.net

hdl.handle.net

Boost MV, O'Donoghue MM, James A (July 2008). "Prevalence of Staphylococcus aureus carriage among dogs and their owners". Epidemiology and Infection. 136 (7): 953–964. doi:10.1017/s0950268807009326. hdl:10397/7558. PMC 2870875. PMID 17678561.
Pader V, Hakim S, Painter KL, Wigneshweraraj S, Clarke TB, Edwards AM (24 October 2016). "Staphylococcus aureus inactivates daptomycin by releasing membrane phospholipids". Nature Microbiology. 2 (1): 16194. doi:10.1038/nmicrobiol.2016.194. hdl:10044/1/40119. ISSN 2058-5276. PMID 27775684.

harvard.edu

ui.adsabs.harvard.edu

Fitzgerald JR, Sturdevant DE, Mackie SM, Gill SR, Musser JM (July 2001). "Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic". Proceedings of the National Academy of Sciences of the United States of America. 98 (15): 8821–6. Bibcode:2001PNAS...98.8821F. doi:10.1073/pnas.161098098. PMC 37519. PMID 11447287.
Fitzgerald JR (January 2014). "Evolution of Staphylococcus aureus during human colonization and infection". Infection, Genetics and Evolution. 21: 542–7. Bibcode:2014InfGE..21..542F. doi:10.1016/j.meegid.2013.04.020. PMID 23624187.
van Belkum A, Melles DC, Nouwen J, van Leeuwen WB, van Wamel W, Vos MC, et al. (January 2009). "Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus". Infection, Genetics and Evolution. 9 (1): 32–47. Bibcode:2009InfGE...9...32V. doi:10.1016/j.meegid.2008.09.012. PMID 19000784.
Zago CE, Silva S, Sanitá PV, Barbugli PA, Dias CM, Lordello VB, et al. (2015). "Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA)". PLOS ONE. 10 (4): e0123206. Bibcode:2015PLoSO..1023206Z. doi:10.1371/journal.pone.0123206. PMC 4395328. PMID 25875834.
Monteith AJ, Miller JM, Maxwell CN, Chazin WJ, Skaar EP (September 2021). "Neutrophil extracellular traps enhance macrophage killing of bacterial pathogens". Science Advances. 7 (37): eabj2101. Bibcode:2021SciA....7.2101M. doi:10.1126/sciadv.abj2101. PMC 8442908. PMID 34516771.
Ulhuq FR, Gomes MC, Duggan GM, Guo M, Mendonca C, Buchanan G, et al. (August 2020). "A membrane-depolarizing toxin substrate of the Staphylococcus aureus type VII secretion system mediates intraspecies competition". Proceedings of the National Academy of Sciences of the United States of America. 117 (34): 20836–47. Bibcode:2020PNAS..11720836U. doi:10.1073/pnas.2006110117. PMC 7456083. PMID 32769205.
Burts ML, Williams WA, DeBord K, Missiakas DM (January 2005). "EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections". Proceedings of the National Academy of Sciences of the United States of America. 102 (4): 1169–74. Bibcode:2005PNAS..102.1169B. doi:10.1073/pnas.0405620102. PMC 545836. PMID 15657139.
Schneewind O, Fowler A, Faull KF (April 1995). "Structure of the cell wall anchor of surface proteins in Staphylococcus aureus". Science. 268 (5207): 103–6. Bibcode:1995Sci...268..103S. doi:10.1126/science.7701329. PMID 7701329.
Liu CI, Liu GY, Song Y, Yin F, Hensler ME, Jeng WY, et al. (March 2008). "A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence". Science. 319 (5868): 1391–4. Bibcode:2008Sci...319.1391L. doi:10.1126/science.1153018. PMC 2747771. PMID 18276850.
Deurenberg RH, Stobberingh EE (December 2008). "The evolution of Staphylococcus aureus". Infection, Genetics and Evolution. 8 (6): 747–763. Bibcode:2008InfGE...8..747D. doi:10.1016/j.meegid.2008.07.007. PMID 18718557.
Korotetskiy IS, Shilov SV, Kuznetsova TV, Zubenko N, Ivanova L, Reva ON (2025). "Epigenetic background of lineage-specific gene expression landscapes of four Staphylococcus aureus hospital isolates". PLOS ONE. 20 (5): e0322006. Bibcode:2025PLoSO..2022006K. doi:10.1371/journal.pone.0322006. PMC 12052166. PMID 40323905.
Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V (September 2000). "Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics". Nature. 407 (6802): 340–8. Bibcode:2000Natur.407..340C. doi:10.1038/35030019. PMID 11014183. S2CID 4408938.
Ledger EV, Mesnage S, Edwards AM (19 April 2022). "Human serum triggers antibiotic tolerance in Staphylococcus aureus". Nature Communications. 13 (1): 2041. Bibcode:2022NatCo..13.2041L. doi:10.1038/s41467-022-29717-3. ISSN 2041-1723. PMC 9018823. PMID 35440121.

horizonpress.com

Francois P, Schrenzel J (2008). "Rapid Diagnosis and Typing of Staphylococcus aureus". Staphylococcus: Molecular Genetics. Caister Academic Press. ISBN 978-1-904455-29-5.

inserm.fr

hal.inserm.fr

Sayed N, Jousselin A, Felden B (December 2011). "A cis-antisense RNA acts in trans in Staphylococcus aureus to control translation of a human cytolytic peptide" (PDF). Nature Structural & Molecular Biology. 19 (1): 105–112. doi:10.1038/nsmb.2193. PMID 22198463. S2CID 8217681.

jamanetwork.com

Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. (17 October 2007). "Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States". JAMA. 298 (15): 1763–1771. doi:10.1001/jama.298.15.1763. ISSN 0098-7484. PMID 17940231.
Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. (9 December 2013). "Health Care–Associated Infections: A Meta-analysis of Costs and Financial Impact on the US Health Care System". JAMA Internal Medicine. 173 (22): 2039–2046. doi:10.1001/jamainternmed.2013.9763. ISSN 2168-6106. PMID 23999949.

jstor.org

Saint-Martin M, Charest G, Desranleau JM (September 1951). "Bacteriophage typing in investigations of staphylococcal food-poisoning outbreaks". Canadian Journal of Public Health. 42 (9): 351–8. JSTOR 41980177. PMID 14879282.

microbenotes.com

"Mannitol Salt Agar (MSA) | Culture Media". Microbe Notes. 14 January 2020. Retrieved 31 December 2020.

nature.com

Pader V, Hakim S, Painter KL, Wigneshweraraj S, Clarke TB, Edwards AM (24 October 2016). "Staphylococcus aureus inactivates daptomycin by releasing membrane phospholipids". Nature Microbiology. 2 (1): 16194. doi:10.1038/nmicrobiol.2016.194. hdl:10044/1/40119. ISSN 2058-5276. PMID 27775684.

news-medical.net

"Intercell, Merck terminate V710 Phase II/III trial against S. aureus infection". Merck & Co. 8 June 2011. Retrieved 7 October 2015.

nice.org.uk

"Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing. NICE guideline [NG190]". National Institute for Health and Care Excellence. 2 March 2021. Retrieved 26 July 2024.

nih.gov

pubmed.ncbi.nlm.nih.gov

Masalha M, Borovok I, Schreiber R, Aharonowitz Y, Cohen G (December 2001). "Analysis of transcription of the Staphylococcus aureus aerobic class Ib and anaerobic class III ribonucleotide reductase genes in response to oxygen". Journal of Bacteriology. 183 (24): 7260–72. doi:10.1128/JB.183.24.7260-7272.2001. PMC 95576. PMID 11717286.
Kluytmans J, van Belkum A, Verbrugh H (July 1997). "Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks". Clinical Microbiology Reviews. 10 (3): 505–520. doi:10.1128/CMR.10.3.505. PMC 172932. PMID 9227864.
Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG (July 2015). "Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management". Clinical Microbiology Reviews. 28 (3): 603–661. doi:10.1128/CMR.00134-14. PMC 4451395. PMID 26016486.
Cole AM, Tahk S, Oren A, Yoshioka D, Kim YH, Park A, et al. (November 2001). "Determinants of Staphylococcus aureus nasal carriage". Clinical and Diagnostic Laboratory Immunology. 8 (6): 1064–9. doi:10.1128/CDLI.8.6.1064-1069.2001. PMC 96227. PMID 11687441.
Senok AC, Verstraelen H, Temmerman M, Botta GA (October 2009). "Probiotics for the treatment of bacterial vaginosis". The Cochrane Database of Systematic Reviews (4): CD006289. doi:10.1002/14651858.CD006289.pub2. PMID 19821358.
Schlecht LM, Peters BM, Krom BP, Freiberg JA, Hänsch GM, Filler SG, et al. (January 2015). "Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue". Microbiology. 161 (Pt 1): 168–181. doi:10.1099/mic.0.083485-0. PMC 4274785. PMID 25332378.
Fitzgerald JR, Sturdevant DE, Mackie SM, Gill SR, Musser JM (July 2001). "Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic". Proceedings of the National Academy of Sciences of the United States of America. 98 (15): 8821–6. Bibcode:2001PNAS...98.8821F. doi:10.1073/pnas.161098098. PMC 37519. PMID 11447287.
Lindsay JA (February 2010). "Genomic variation and evolution of Staphylococcus aureus". International Journal of Medical Microbiology. 300 (2–3): 98–103. doi:10.1016/j.ijmm.2009.08.013. PMID 19811948.
Fitzgerald JR (January 2014). "Evolution of Staphylococcus aureus during human colonization and infection". Infection, Genetics and Evolution. 21: 542–7. Bibcode:2014InfGE..21..542F. doi:10.1016/j.meegid.2013.04.020. PMID 23624187.
van Belkum A, Melles DC, Nouwen J, van Leeuwen WB, van Wamel W, Vos MC, et al. (January 2009). "Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus". Infection, Genetics and Evolution. 9 (1): 32–47. Bibcode:2009InfGE...9...32V. doi:10.1016/j.meegid.2008.09.012. PMID 19000784.
Varrone JJ, de Mesy Bentley KL, Bello-Irizarry SN, Nishitani K, Mack S, Hunter JG, et al. (October 2014). "Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters". Journal of Orthopaedic Research. 32 (10): 1389–96. doi:10.1002/jor.22672. PMC 4234088. PMID 24992290.
Matthews KR, Roberson J, Gillespie BE, Luther DA, Oliver SP (June 1997). "Identification and Differentiation of Coagulase-Negative Staphylococcus aureus by Polymerase Chain Reaction". Journal of Food Protection. 60 (6): 686–8. doi:10.4315/0362-028X-60.6.686. PMID 31195568.
Morikawa K, Takemura AJ, Inose Y, Tsai M, Nguyen TL, Ohta T, et al. (2012). "Expression of a cryptic secondary sigma factor gene unveils natural competence for DNA transformation in Staphylococcus aureus". PLOS Pathogens. 8 (11): e1003003. doi:10.1371/journal.ppat.1003003. PMC 3486894. PMID 23133387.
Fagerlund A, Granum PE, Håvarstein LS (November 2014). "Staphylococcus aureus competence genes: mapping of the SigH, ComK1 and ComK2 regulons by transcriptome sequencing". Molecular Microbiology. 94 (3): 557–579. doi:10.1111/mmi.12767. PMID 25155269. S2CID 1568023.
Schenck LP, Surette MG, Bowdish DM (November 2016). "Composition and immunological significance of the upper respiratory tract microbiota". FEBS Letters. 590 (21): 3705–20. doi:10.1002/1873-3468.12455. PMC 7164007. PMID 27730630.
Wollina U (2017). "Microbiome in atopic dermatitis". Clinical, Cosmetic and Investigational Dermatology. 10: 51–56. doi:10.2147/CCID.S130013. PMC 5327846. PMID 28260936.
Otto M (April 2010). "Staphylococcus colonization of the skin and antimicrobial peptides". Expert Review of Dermatology. 5 (2): 183–195. doi:10.1586/edm.10.6. PMC 2867359. PMID 20473345.
Roberts RR, Hota B, Ahmad I, Scott R. Douglas, II, Foster SD, Abbasi F, et al. (15 October 2009). "Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship". Clinical Infectious Diseases. 49 (8): 1175–1184. doi:10.1086/605630. ISSN 1058-4838. PMID 19739972.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. (17 October 2007). "Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States". JAMA. 298 (15): 1763–1771. doi:10.1001/jama.298.15.1763. ISSN 0098-7484. PMID 17940231.
Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. (9 December 2013). "Health Care–Associated Infections: A Meta-analysis of Costs and Financial Impact on the US Health Care System". JAMA Internal Medicine. 173 (22): 2039–2046. doi:10.1001/jamainternmed.2013.9763. ISSN 2168-6106. PMID 23999949.
Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. (May 2010). "Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)". Infection Control & Hospital Epidemiology. 31 (5): 431–455. doi:10.1086/651706. ISSN 0899-823X. PMID 20307191.
Kourtis AP (2019). "Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States". MMWR. Morbidity and Mortality Weekly Report. 68 (9): 214–219. doi:10.15585/mmwr.mm6809e1. ISSN 0149-2195. PMC 6421967. PMID 30845118.
Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, et al. (25 November 2013). "National Burden of Invasive Methicillin-Resistant Staphylococcus aureus Infections, United States, 2011". JAMA Internal Medicine. 173 (21): 1970–1978. doi:10.1001/jamainternmed.2013.10423. ISSN 2168-6106. PMC 10887428. PMID 24043270.
Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, Jernigan DB (June 2005). "Methicillin-resistant-Staphylococcus aureus hospitalizations, United States". Emerging Infectious Diseases. 11 (6): 868–872. doi:10.3201/eid1106.040831. PMC 3367609. PMID 15963281.
Kavanaugh JS, Horswill AR (June 2016). "Impact of Environmental Cues on Staphylococcal Quorum Sensing and Biofilm Development". The Journal of Biological Chemistry (Review). 291 (24): 12556–64. doi:10.1074/jbc.R116.722710. PMC 4933443. PMID 27129223.
Monnot GC, Wegrecki M, Cheng TY, Chen YL, Sallee BN, Chakravarthy R, et al. (January 2023). "Staphylococcal phosphatidylglycerol antigens activate human T cells via CD1a". Nature Immunology. 24 (1): 110–122. doi:10.1038/s41590-022-01375-z. PMC 10389259. PMID 35265979. S2CID 255039948.
Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH, et al. (April 2015). "Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis". Immunity. 42 (4): 756–766. doi:10.1016/j.immuni.2015.03.014. PMC 4407815. PMID 25902485.
Nakatsuji T, Chen TH, Two AM, Chun KA, Narala S, Geha RS, et al. (November 2016). "Staphylococcus aureus Exploits Epidermal Barrier Defects in Atopic Dermatitis to Trigger Cytokine Expression". The Journal of Investigative Dermatology. 136 (11): 2192–2200. doi:10.1016/j.jid.2016.05.127. PMC 5103312. PMID 27381887.
Curran JP, Al-Salihi FL (August 1980). "Neonatal staphylococcal scalded skin syndrome: massive outbreak due to an unusual phage type". Pediatrics. 66 (2): 285–290. doi:10.1542/peds.66.2.285. PMID 6447271. S2CID 21783186.
Gallo RL, Horswill AR (May 2024). "Staphylococcus aureus: The Bug Behind the Itch in Atopic Dermatitis". Journal of Investigative Dermatology. 144 (5): 950–953. doi:10.1016/j.jid.2024.01.001. PMID 38430083.
George SM, Karanovic S, Harrison DA, Rani A, Birnie AJ, Bath-Hextall FJ, et al. (October 2019). "Interventions to reduce Staphylococcus aureus in the management of eczema". The Cochrane Database of Systematic Reviews. 2019 (10). doi:10.1002/14651858.CD003871.pub3. PMC 6818407. PMID 31684694.
Rasmussen RV, Fowler VG, Skov R, Bruun NE (January 2011). "Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA". Future Microbiology. 6 (1): 43–56. doi:10.2217/fmb.10.155. PMC 3031962. PMID 21162635.
Latha T, Anil B, Manjunatha H, Chiranjay M, Elsa D, Baby N, et al. (March 2019). "MRSA: the leading pathogen of orthopedic infection in a tertiary care hospital, South India". Afr Health Sci. 19 (1): 1393–1401. doi:10.4314/ahs.v19i1.12. PMC 6531934. PMID 31148966.
Zago CE, Silva S, Sanitá PV, Barbugli PA, Dias CM, Lordello VB, et al. (2015). "Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA)". PLOS ONE. 10 (4): e0123206. Bibcode:2015PLoSO..1023206Z. doi:10.1371/journal.pone.0123206. PMC 4395328. PMID 25875834.
Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME (1 September 2011). "Staphylococcus aureus biofilms: properties, regulation, and roles in human disease". Virulence. 2 (5): 445–459. doi:10.4161/viru.2.5.17724. PMC 3322633. PMID 21921685.
Chung PY, Toh YS (April 2014). "Anti-biofilm agents: recent breakthrough against multi-drug resistant Staphylococcus aureus". Pathogens and Disease. 70 (3): 231–9. doi:10.1111/2049-632x.12141. PMID 24453168.
Hogan S, Zapotoczna M, Stevens NT, Humphreys H, O'Gara JP, O'Neill E (June 2017). "Potential use of targeted enzymatic agents in the treatment of Staphylococcus aureus biofilm-related infections". The Journal of Hospital Infection. 96 (2): 177–182. doi:10.1016/j.jhin.2017.02.008. PMID 28351512.
Boost MV, O'Donoghue MM, James A (July 2008). "Prevalence of Staphylococcus aureus carriage among dogs and their owners". Epidemiology and Infection. 136 (7): 953–964. doi:10.1017/S0950268807009326. PMC 2870875. PMID 17678561.
Hanselman BA, Kruth SA, Rousseau J, Weese JS (September 2009). "Coagulase positive staphylococcal colonization of humans and their household pets". The Canadian Veterinary Journal. 50 (9): 954–8. PMC 2726022. PMID 19949556.
Burton S, Reid-Smith R, McClure JT, Weese JS (August 2008). "Staphylococcus aureus colonization in healthy horses in Atlantic Canada". The Canadian Veterinary Journal. 49 (8): 797–9. PMC 2465786. PMID 18978975.
Boost MV, O'Donoghue MM, James A (July 2008). "Prevalence of Staphylococcus aureus carriage among dogs and their owners". Epidemiology and Infection. 136 (7): 953–964. doi:10.1017/s0950268807009326. hdl:10397/7558. PMC 2870875. PMID 17678561.
Cenci-Goga BT, Karama M, Rossitto PV, Morgante RA, Cullor JS (September 2003). "Enterotoxin production by Staphylococcus aureus isolated from mastitic cows" (PDF). Journal of Food Protection. 66 (9): 1693–6. doi:10.4315/0362-028X-66.9.1693. PMID 14503727.
Cheung GY, Bae JS, Otto M (December 2021). "Pathogenicity and virulence of Staphylococcus aureus". Virulence. 12 (1): 547–569. doi:10.1080/21505594.2021.1878688. PMC 7872022. PMID 33522395.
Berends ET, Horswill AR, Haste NM, Monestier M, Nizet V, von Köckritz-Blickwede M (2010). "Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps". Journal of Innate Immunity. 2 (6): 576–586. doi:10.1159/000319909. PMC 2982853. PMID 20829609.
Monteith AJ, Miller JM, Maxwell CN, Chazin WJ, Skaar EP (September 2021). "Neutrophil extracellular traps enhance macrophage killing of bacterial pathogens". Science Advances. 7 (37): eabj2101. Bibcode:2021SciA....7.2101M. doi:10.1126/sciadv.abj2101. PMC 8442908. PMID 34516771.
Dinges MM, Orwin PM, Schlievert PM (January 2000). "Exotoxins of Staphylococcus aureus". Clinical Microbiology Reviews. 13 (1): 16–34, table of contents. doi:10.1128/cmr.13.1.16. PMC 88931. PMID 10627489.
Etter D, Schelin J, Schuppler M, Johler S (September 2020). "Staphylococcal Enterotoxin C-An Update on SEC Variants, Their Structure and Properties, and Their Role in Foodborne Intoxications". Toxins. 12 (9): 584. doi:10.3390/toxins12090584. PMC 7551944. PMID 32927913.
Jarraud S, Peyrat MA, Lim A, Tristan A, Bes M, Mougel C, et al. (January 2001). "egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus". Journal of Immunology. 166 (1): 669–677. doi:10.4049/jimmunol.166.1.669. PMID 11123352.
Becker K, Friedrich AW, Lubritz G, Weilert M, Peters G, Von Eiff C (April 2003). "Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens". Journal of Clinical Microbiology. 41 (4): 1434–9. doi:10.1128/jcm.41.4.1434-1439.2003. PMC 153929. PMID 12682126.
Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. (November 1999). "Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia". Clinical Infectious Diseases. 29 (5): 1128–32. doi:10.1086/313461. PMID 10524952.
Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. (March 2002). "Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients". Lancet. 359 (9308): 753–9. doi:10.1016/S0140-6736(02)07877-7. PMID 11888586. S2CID 20400336. As PDF Archived 14 July 2014 at the Wayback Machine
Bowman L, Palmer T (October 2021). "The Type VII Secretion System of Staphylococcus". Annual Review of Microbiology. 75 (1): 471–494. doi:10.1146/annurev-micro-012721-123600. PMID 34343022. S2CID 236915377.
Cao Z, Casabona MG, Kneuper H, Chalmers JD, Palmer T (October 2016). "The type VII secretion system of Staphylococcus aureus secretes a nuclease toxin that targets competitor bacteria". Nature Microbiology. 2 (1): 16183. doi:10.1038/nmicrobiol.2016.183. PMC 5325307. PMID 27723728.
Ulhuq FR, Gomes MC, Duggan GM, Guo M, Mendonca C, Buchanan G, et al. (August 2020). "A membrane-depolarizing toxin substrate of the Staphylococcus aureus type VII secretion system mediates intraspecies competition". Proceedings of the National Academy of Sciences of the United States of America. 117 (34): 20836–47. Bibcode:2020PNAS..11720836U. doi:10.1073/pnas.2006110117. PMC 7456083. PMID 32769205.
Burts ML, Williams WA, DeBord K, Missiakas DM (January 2005). "EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections". Proceedings of the National Academy of Sciences of the United States of America. 102 (4): 1169–74. Bibcode:2005PNAS..102.1169B. doi:10.1073/pnas.0405620102. PMC 545836. PMID 15657139.
Dai Y, Wang Y, Liu Q, Gao Q, Lu H, Meng H, et al. (5 May 2017). "A Novel ESAT-6 Secretion System-Secreted Protein EsxX of Community-Associated Staphylococcus aureus Lineage ST398 Contributes to Immune Evasion and Virulence". Frontiers in Microbiology. 8: 819. doi:10.3389/fmicb.2017.00819. PMC 5418362. PMID 28529509.
Kim S, Reyes D, Beaume M, Francois P, Cheung A (October 2014). "Contribution of teg49 small RNA in the 5' upstream transcriptional region of sarA to virulence in Staphylococcus aureus". Infection and Immunity. 82 (10): 4369–79. doi:10.1128/iai.02002-14. PMC 4187880. PMID 25092913.
Chevalier C, Boisset S, Romilly C, Masquida B, Fechter P, Geissmann T, et al. (March 2010). "Staphylococcus aureus RNAIII binds to two distant regions of coa mRNA to arrest translation and promote mRNA degradation". PLOS Pathogens. 6 (3): e1000809. doi:10.1371/journal.ppat.1000809. PMC 2837412. PMID 20300607.
Chabelskaya S, Gaillot O, Felden B (June 2010). "A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule". PLOS Pathogens. 6 (6): e1000927. doi:10.1371/journal.ppat.1000927. PMC 2880579. PMID 20532214.
Le Pabic H, Germain-Amiot N, Bordeau V, Felden B (October 2015). "A bacterial regulatory RNA attenuates virulence, spread and human host cell phagocytosis". Nucleic Acids Research. 43 (19): 9232–48. doi:10.1093/nar/gkv783. PMC 4627067. PMID 26240382.
Mauro T, Rouillon A, Felden B (December 2016). "Insights into the regulation of small RNA expression: SarA represses the expression of two sRNAs in Staphylococcus aureus". Nucleic Acids Research. 44 (21): 10186–200. doi:10.1093/nar/gkw777. PMC 5137438. PMID 27596601.
Bohn C, Rigoulay C, Chabelskaya S, Sharma CM, Marchais A, Skorski P, et al. (October 2010). "Experimental discovery of small RNAs in Staphylococcus aureus reveals a riboregulator of central metabolism". Nucleic Acids Research. 38 (19): 6620–36. doi:10.1093/nar/gkq462. PMC 2965222. PMID 20511587.
Sayed N, Jousselin A, Felden B (December 2011). "A cis-antisense RNA acts in trans in Staphylococcus aureus to control translation of a human cytolytic peptide" (PDF). Nature Structural & Molecular Biology. 19 (1): 105–112. doi:10.1038/nsmb.2193. PMID 22198463. S2CID 8217681.
Morrison JM, Miller EW, Benson MA, Alonzo F, Yoong P, Torres VJ, et al. (June 2012). "Characterization of SSR42, a novel virulence factor regulatory RNA that contributes to the pathogenesis of a Staphylococcus aureus USA300 representative". Journal of Bacteriology. 194 (11): 2924–38. doi:10.1128/JB.06708-11. PMC 3370614. PMID 22493015.
Xue T, Zhang X, Sun H, Sun B (February 2014). "ArtR, a novel sRNA of Staphylococcus aureus, regulates α-toxin expression by targeting the 5' UTR of sarT mRNA". Medical Microbiology and Immunology. 203 (1): 1–12. doi:10.1007/s00430-013-0307-0. PMID 23955428. S2CID 18371872.
Coronel-Tellez RH, Pospiech M, Barrault M, Liu W, Bordeau V, Vasnier C, et al. (August 2022). "sRNA-controlled iron sparing response in Staphylococci". Nucleic Acids Research. 50 (15): 8529–8546. doi:10.1093/nar/gkac648. PMC 9410917. PMID 35904807.
Ha KP, Clarke RS, Kim GL, Brittan JL, Rowley JE, Mavridou DA, et al. (November 2020). "Staphylococcal DNA Repair Is Required for Infection". mBio. 11 (6): e02288-20. doi:10.1128/mBio.02288-20. PMC 7683395. PMID 33203752.
Ruiz de los Mozos I, Vergara-Irigaray M, Segura V, Villanueva M, Bitarte N, Saramago M, et al. (2013). "Base pairing interaction between 5'- and 3'-UTRs controls icaR mRNA translation in Staphylococcus aureus". PLOS Genetics. 9 (12): e1004001. doi:10.1371/journal.pgen.1004001. PMC 3868564. PMID 24367275.
Arciola CR, Campoccia D, Speziale P, Montanaro L, Costerton JW (September 2012). "Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials". Biomaterials. 33 (26): 5967–82. doi:10.1016/j.biomaterials.2012.05.031. PMID 22695065.
de la Fuente-Núñez C, Reffuveille F, Fernández L, Hancock RE (October 2013). "Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies". Current Opinion in Microbiology. 16 (5): 580–9. doi:10.1016/j.mib.2013.06.013. PMID 23880136.
McLaughlin RA, Hoogewerf AJ (August 2006). "Interleukin-1beta-induced growth enhancement of Staphylococcus aureus occurs in biofilm but not planktonic cultures". Microbial Pathogenesis. 41 (2–3): 67–79. doi:10.1016/j.micpath.2006.04.005. PMID 16769197.
Nassar R, Hachim M, Nassar M, Kaklamanos EG, Jamal M, Williams D, et al. (2021). "Microbial Metabolic Genes Crucial for S. aureus Biofilms: An Insight From Re-analysis of Publicly Available Microarray Datasets". Frontiers in Microbiology. 11: 607002. doi:10.3389/fmicb.2020.607002. PMC 7876462. PMID 33584569.
Schneewind O, Fowler A, Faull KF (April 1995). "Structure of the cell wall anchor of surface proteins in Staphylococcus aureus". Science. 268 (5207): 103–6. Bibcode:1995Sci...268..103S. doi:10.1126/science.7701329. PMID 7701329.
Patel AH, Nowlan P, Weavers ED, Foster T (December 1987). "Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement". Infection and Immunity. 55 (12): 3103–10. doi:10.1128/IAI.55.12.3103-3110.1987. PMC 260034. PMID 3679545.
Zhu J, Lu C, Standland M, Lai E, Moreno GN, Umeda A, et al. (February 2008). "Single mutation on the surface of Staphylococcus aureus Sortase A can disrupt its dimerization". Biochemistry. 47 (6): 1667–74. doi:10.1021/bi7014597. PMID 18193895.
Clauditz A, Resch A, Wieland KP, Peschel A, Götz F (August 2006). "Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress". Infection and Immunity. 74 (8): 4950–3. doi:10.1128/IAI.00204-06. PMC 1539600. PMID 16861688.
Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, et al. (July 2005). "Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity". The Journal of Experimental Medicine. 202 (2): 209–215. doi:10.1084/jem.20050846. PMC 2213009. PMID 16009720.
Liu CI, Liu GY, Song Y, Yin F, Hensler ME, Jeng WY, et al. (March 2008). "A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence". Science. 319 (5868): 1391–4. Bibcode:2008Sci...319.1391L. doi:10.1126/science.1153018. PMC 2747771. PMID 18276850.
Barrett TJ, Hawkins CL (2012). "Hypothiocyanous Acid: Benign or Deadly?". Chemical Research in Toxicology. 25 (2): 263–273. doi:10.1021/tx200219s. PMID 22053976.
Loi VV, Busche T, Schnaufer F, Kalinowski J, Antelmann H (2023). "The neutrophil oxidant hypothiocyanous acid causes a thiol-specific stress response and an oxidative shift of the bacillithiol redox potential in Staphylococcus aureus". Microbiology Spectrum. 11 (6): e03252-23. doi:10.1128/spectrum.03252-23. PMC 10715087. PMID 37930020.
Shearer HL, Loi VV, Weiland P, Bange G, Altegoer F, Hampton MB, et al. (2023). "MerA functions as a hypothiocyanous acid reductase and defense mechanism in Staphylococcus aureus". Molecular Microbiology. 119 (4): 456–470. doi:10.1111/MMI.15035. PMID 36779383.
Shearer HL, Pace PE, Paton JC, Hampton MB, Dickerhof N (2022). "A newly identified flavoprotein disulfide reductase Har protects Streptococcus pneumoniae against hypothiocyanous acid". Journal of Biological Chemistry. 298 (9): 102359. doi:10.1016/J.JBC.2022.102359. PMC 9483559. PMID 35952759.
Saint-Martin M, Charest G, Desranleau JM (September 1951). "Bacteriophage typing in investigations of staphylococcal food-poisoning outbreaks". Canadian Journal of Public Health. 42 (9): 351–8. JSTOR 41980177. PMID 14879282.
Deurenberg RH, Stobberingh EE (December 2008). "The evolution of Staphylococcus aureus". Infection, Genetics and Evolution. 8 (6): 747–763. Bibcode:2008InfGE...8..747D. doi:10.1016/j.meegid.2008.07.007. PMID 18718557.
Aires de Sousa M, Conceição T, Simas C, de Lencastre H (October 2005). "Comparison of genetic backgrounds of methicillin-resistant and -susceptible Staphylococcus aureus isolates from Portuguese hospitals and the community". Journal of Clinical Microbiology. 43 (10): 5150–7. doi:10.1128/JCM.43.10.5150-5157.2005. PMC 1248511. PMID 16207977.
Korzeniowski O, Sande MA (October 1982). "Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study". Annals of Internal Medicine. 97 (4): 496–503. doi:10.7326/0003-4819-97-4-496. PMID 6751182.
Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, et al. (1998). "Diagnosis and management of infective endocarditis and its complications". Circulation. 98 (25): 2936–48. doi:10.1161/01.CIR.98.25.2936. PMID 9860802.
Cosgrove SE, Vigliani GA, Fowler VG, Abrutyn E, Corey GR, Levine DP, et al. (March 2009). "Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic". Clinical Infectious Diseases. 48 (6): 713–721. doi:10.1086/597031. PMID 19207079.
Thwaites GE, Scarborough M, Szubert A, Nsutebu E, Tilley R, Greig J, et al. (February 2018). "Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial". Lancet. 391 (10121): 668–678. doi:10.1016/S0140-6736(17)32456-X. PMC 5820409. PMID 29249276.
Chambers HF (2001). "The changing epidemiology of Staphylococcus aureus?". Emerging Infectious Diseases. 7 (2): 178–182. doi:10.3201/eid0702.010204. PMC 2631711. PMID 11294701.
Bonomo RA, Van Zile PS, Li Q, Shermock KM, McCormick WG, Kohut B (October 2007). "Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspective". Expert Review of Anti-Infective Therapy. 5 (5): 773–782. doi:10.1586/14787210.5.5.773. PMID 17914912. S2CID 31594289.
Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. (Antimicrobial Resistance Collaborators) (February 2022). "Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis". Lancet. 399 (10325): 629–655. doi:10.1016/S0140-6736(21)02724-0. PMC 8841637. PMID 35065702.
Korotetskiy IS, Shilov SV, Kuznetsova TV, Zubenko N, Ivanova L, Reva ON (2025). "Epigenetic background of lineage-specific gene expression landscapes of four Staphylococcus aureus hospital isolates". PLOS ONE. 20 (5): e0322006. Bibcode:2025PLoSO..2022006K. doi:10.1371/journal.pone.0322006. PMC 12052166. PMID 40323905.
Jamrozy D, Coll F, Mather AE, Harris SR, Harrison EM, MacGowan A, et al. (September 2017). "Evolution of mobile genetic element composition in an epidemic methicillin-resistant Staphylococcus aureus: temporal changes correlated with frequent loss and gain events". BMC Genomics. 18 (1): 684. doi:10.1186/s12864-017-4065-z. PMC 5584012. PMID 28870171.
Pozzi C, Waters EM, Rudkin JK, Schaeffer CR, Lohan AJ, Tong P, et al. (5 April 2012). Sullam PM (ed.). "Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections". PLOS Pathogens. 8 (4): e1002626. doi:10.1371/journal.ppat.1002626. PMC 3320603. PMID 22496652.
Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V (September 2000). "Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics". Nature. 407 (6802): 340–8. Bibcode:2000Natur.407..340C. doi:10.1038/35030019. PMID 11014183. S2CID 4408938.
Sakon J, Liao HH, Kanikula AM, Benning MM, Rayment I, Holden HM (November 1993). "Molecular structure of kanamycin nucleotidyltransferase determined to 3.0-A resolution". Biochemistry. 32 (45): 11977–84. doi:10.1021/bi00096a006. PMID 8218273.
Arthur M, Courvalin P (August 1993). "Genetics and mechanisms of glycopeptide resistance in enterococci". Antimicrobial Agents and Chemotherapy. 37 (8). ASM: 1563–71. doi:10.1128/AAC.37.8.1563. PMC 188020. PMID 8215264.
Rolinson GN, Stevens S, Batchelor FR, Wood JC, Chain EB (September 1960). "Bacteriological studies on a new penicillin-BRL. 1241". Lancet. 2 (7150): 564–7. doi:10.1136/bmj.1.5219.124-a. PMC 1952878. PMID 14438510.
Johnson AP, Aucken HM, Cavendish S, Ganner M, Wale MC, Warner M, et al. (July 2001). "Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS)". The Journal of Antimicrobial Chemotherapy. 48 (1): 143–4. doi:10.1093/jac/48.1.143. PMID 11418528.
Chen CJ, Huang YC (August 2018). "Emergence of livestock-associated methicillin-resistant Staphylococcus aureus: Should it be a concern?". Journal of the Formosan Medical Association = Taiwan Yi Zhi. 117 (8): 658–661. doi:10.1016/j.jfma.2018.04.004. PMID 29754805. S2CID 21659477.
^{[verification needed]}Blot SI, Vandewoude KH, Hoste EA, Colardyn FA (October 2002). "Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus". Archives of Internal Medicine. 162 (19): 2229–35. doi:10.1001/archinte.162.19.2229. PMID 12390067.
Pader V, Hakim S, Painter KL, Wigneshweraraj S, Clarke TB, Edwards AM (24 October 2016). "Staphylococcus aureus inactivates daptomycin by releasing membrane phospholipids". Nature Microbiology. 2 (1): 16194. doi:10.1038/nmicrobiol.2016.194. hdl:10044/1/40119. ISSN 2058-5276. PMID 27775684.
Yang SJ, Bayer AS, Mishra NN, Meehl M, Ledala N, Yeaman MR, et al. (22 December 2012). "The Staphylococcus aureus Two-Component Regulatory System, GraRS, Senses and Confers Resistance to Selected Cationic Antimicrobial Peptides". Infection and Immunity. 80 (1): 74–81. doi:10.1128/iai.05669-11. PMC 3255649. PMID 21986630.
Ledger EV, Mesnage S, Edwards AM (19 April 2022). "Human serum triggers antibiotic tolerance in Staphylococcus aureus". Nature Communications. 13 (1): 2041. Bibcode:2022NatCo..13.2041L. doi:10.1038/s41467-022-29717-3. ISSN 2041-1723. PMC 9018823. PMID 35440121.
Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (July 1997). "Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility". The Journal of Antimicrobial Chemotherapy. 40 (1): 135–6. doi:10.1093/jac/40.1.135. PMID 9249217.
Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. (April 2003). "Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene". The New England Journal of Medicine. 348 (14): 1342–7. doi:10.1056/NEJMoa025025. PMID 12672861.
Menichetti F (May 2005). "Current and emerging serious Gram-positive infections". Clinical Microbiology and Infection. 11 (Suppl 3): 22–28. doi:10.1111/j.1469-0691.2005.01138.x. PMID 15811021.
Sengupta M, Jain V, Wilkinson BJ, Jayaswal RK (June 2012). "Chromatin immunoprecipitation identifies genes under direct VraSR regulation in Staphylococcus aureus". Canadian Journal of Microbiology. 58 (6): 703–8. doi:10.1139/w2012-043. PMID 22571705.
Holasová K, Křížkovská B, Hoang L, Dobiasová S, Lipov J, Macek T, et al. (May 2022). "Flavonolignans from silymarin modulate antibiotic resistance and virulence in Staphylococcus aureus". Biomedicine & Pharmacotherapy. 149: 112806. doi:10.1016/j.biopha.2022.112806. PMID 35303568.
Campos A, Arias A, Betancor L, Rodríguez C, Hernández AM, López Aguado D, et al. (July 1998). "Study of common aerobic flora of human cerumen". The Journal of Laryngology and Otology. 112 (7): 613–6. doi:10.1017/s002221510014126x. PMID 9775288. S2CID 29362695.
Quinn GA, Cole AM (September 2007). "Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium". Immunology. 122 (1): 80–89. doi:10.1111/j.1365-2567.2007.02615.x. PMC 2265977. PMID 17472720.
Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. (December 2005). "The role of nasal carriage in Staphylococcus aureus infections". The Lancet. Infectious Diseases. 5 (12): 751–762. doi:10.1016/S1473-3099(05)70295-4. PMID 16310147.
Munir MT, Pailhories H, Eveillard M, Irle M, Aviat F, Federighi M, et al. (August 2020). "Experimental Parameters Influence the Observed Antimicrobial Response of Oak Wood (Quercus petraea)". Antibiotics. 9 (9): 535. doi:10.3390/antibiotics9090535. PMC 7558063. PMID 32847132.
Neely AN, Maley MP (February 2000). "Survival of enterococci and staphylococci on hospital fabrics and plastic". Journal of Clinical Microbiology. 38 (2): 724–6. doi:10.1128/JCM.38.2.724-726.2000. PMC 86187. PMID 10655374.
Cook HA, Furuya EY, Larson E, Vasquez G, Lowy FD (February 2007). "Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus". Clinical Infectious Diseases. 44 (3): 410–3. doi:10.1086/510681. PMID 17205449.
Wu X, Su YC (August 2014). "Effects of frozen storage on survival of Staphylococcus aureus and enterotoxin production in precooked tuna meat". Journal of Food Science. 79 (8): M1554 – M1559. doi:10.1111/1750-3841.12530. PMID 25039601.
van Rijen M, Bonten M, Wenzel R, Kluytmans J, et al. (Cochrane Wounds Group) (October 2008). "Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers". The Cochrane Database of Systematic Reviews. 2011 (4): CD006216. doi:10.1002/14651858.CD006216.pub2. PMC 8988859. PMID 18843708.
Liu Z, Norman G, Iheozor-Ejiofor Z, Wong JK, Crosbie EJ, Wilson P, et al. (Cochrane Wounds Group) (May 2017). "Nasal decontamination for the prevention of surgical site infection in Staphylococcus aureus carriers". The Cochrane Database of Systematic Reviews. 5 (8): CD012462. doi:10.1002/14651858.CD012462.pub2. PMC 6481881. PMID 28516472.
Begier E, Seiden DJ, Patton M, Zito E, Severs J, Cooper D, et al. (February 2017). "SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies". Vaccine. 35 (8): 1132–9. doi:10.1016/j.vaccine.2017.01.024. PMID 28143674.
Torre A, Bacconi M, Sammicheli C, Galletti B, Laera D, Fontana MR, et al. (August 2015). "Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice". Infection and Immunity. 83 (8): 3157–63. doi:10.1128/IAI.00258-15. PMC 4496606. PMID 26015481.
Scheper H, Wubbolts JM, Verhagen JA, de Visser AW, van der Wal RJ, Visser LG, et al. (29 January 2021). "SAAP-148 Eradicates MRSA Persisters Within Mature Biofilm Models Simulating Prosthetic Joint Infection". Frontiers in Microbiology. 12: 625952. doi:10.3389/fmicb.2021.625952. PMC 7879538. PMID 33584628.
van den Biggelaar RH, Walburg KV, van den Eeden SJ, van Doorn CL, Meiler E, de Ries AS, et al. (2024). "Identification of kinase modulators as host-directed therapeutics against intracellular methicillin-resistant Staphylococcus aureus". Frontiers in Cellular and Infection Microbiology. 14: 1367938. doi:10.3389/fcimb.2024.1367938. PMC 10999543. PMID 38590439.
Mayr-Harting A (August 1955). "The acquisition of penicillin resistance by Staphylococcus aureus, strain Oxford". Journal of General Microbiology. 13 (1): 9–21. doi:10.1099/00221287-13-1-9. PMID 13252206.
Kearns AM, Ganner M, Holmes A (August 2006). "The 'Oxford Staphylococcus': a note of caution". The Journal of Antimicrobial Chemotherapy. 58 (2): 480–1. doi:10.1093/jac/dkl230. PMID 16735421.

ncbi.nlm.nih.gov

Masalha M, Borovok I, Schreiber R, Aharonowitz Y, Cohen G (December 2001). "Analysis of transcription of the Staphylococcus aureus aerobic class Ib and anaerobic class III ribonucleotide reductase genes in response to oxygen". Journal of Bacteriology. 183 (24): 7260–72. doi:10.1128/JB.183.24.7260-7272.2001. PMC 95576. PMID 11717286.
Kluytmans J, van Belkum A, Verbrugh H (July 1997). "Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks". Clinical Microbiology Reviews. 10 (3): 505–520. doi:10.1128/CMR.10.3.505. PMC 172932. PMID 9227864.
Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG (July 2015). "Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management". Clinical Microbiology Reviews. 28 (3): 603–661. doi:10.1128/CMR.00134-14. PMC 4451395. PMID 26016486.
Cole AM, Tahk S, Oren A, Yoshioka D, Kim YH, Park A, et al. (November 2001). "Determinants of Staphylococcus aureus nasal carriage". Clinical and Diagnostic Laboratory Immunology. 8 (6): 1064–9. doi:10.1128/CDLI.8.6.1064-1069.2001. PMC 96227. PMID 11687441.
Schlecht LM, Peters BM, Krom BP, Freiberg JA, Hänsch GM, Filler SG, et al. (January 2015). "Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue". Microbiology. 161 (Pt 1): 168–181. doi:10.1099/mic.0.083485-0. PMC 4274785. PMID 25332378.
Fitzgerald JR, Sturdevant DE, Mackie SM, Gill SR, Musser JM (July 2001). "Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic". Proceedings of the National Academy of Sciences of the United States of America. 98 (15): 8821–6. Bibcode:2001PNAS...98.8821F. doi:10.1073/pnas.161098098. PMC 37519. PMID 11447287.
Varrone JJ, de Mesy Bentley KL, Bello-Irizarry SN, Nishitani K, Mack S, Hunter JG, et al. (October 2014). "Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters". Journal of Orthopaedic Research. 32 (10): 1389–96. doi:10.1002/jor.22672. PMC 4234088. PMID 24992290.
Morikawa K, Takemura AJ, Inose Y, Tsai M, Nguyen TL, Ohta T, et al. (2012). "Expression of a cryptic secondary sigma factor gene unveils natural competence for DNA transformation in Staphylococcus aureus". PLOS Pathogens. 8 (11): e1003003. doi:10.1371/journal.ppat.1003003. PMC 3486894. PMID 23133387.
Schenck LP, Surette MG, Bowdish DM (November 2016). "Composition and immunological significance of the upper respiratory tract microbiota". FEBS Letters. 590 (21): 3705–20. doi:10.1002/1873-3468.12455. PMC 7164007. PMID 27730630.
Wollina U (2017). "Microbiome in atopic dermatitis". Clinical, Cosmetic and Investigational Dermatology. 10: 51–56. doi:10.2147/CCID.S130013. PMC 5327846. PMID 28260936.
Otto M (April 2010). "Staphylococcus colonization of the skin and antimicrobial peptides". Expert Review of Dermatology. 5 (2): 183–195. doi:10.1586/edm.10.6. PMC 2867359. PMID 20473345.
Kourtis AP (2019). "Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States". MMWR. Morbidity and Mortality Weekly Report. 68 (9): 214–219. doi:10.15585/mmwr.mm6809e1. ISSN 0149-2195. PMC 6421967. PMID 30845118.
Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, et al. (25 November 2013). "National Burden of Invasive Methicillin-Resistant Staphylococcus aureus Infections, United States, 2011". JAMA Internal Medicine. 173 (21): 1970–1978. doi:10.1001/jamainternmed.2013.10423. ISSN 2168-6106. PMC 10887428. PMID 24043270.
Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, Jernigan DB (June 2005). "Methicillin-resistant-Staphylococcus aureus hospitalizations, United States". Emerging Infectious Diseases. 11 (6): 868–872. doi:10.3201/eid1106.040831. PMC 3367609. PMID 15963281.
Kavanaugh JS, Horswill AR (June 2016). "Impact of Environmental Cues on Staphylococcal Quorum Sensing and Biofilm Development". The Journal of Biological Chemistry (Review). 291 (24): 12556–64. doi:10.1074/jbc.R116.722710. PMC 4933443. PMID 27129223.
Monnot GC, Wegrecki M, Cheng TY, Chen YL, Sallee BN, Chakravarthy R, et al. (January 2023). "Staphylococcal phosphatidylglycerol antigens activate human T cells via CD1a". Nature Immunology. 24 (1): 110–122. doi:10.1038/s41590-022-01375-z. PMC 10389259. PMID 35265979. S2CID 255039948.
Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH, et al. (April 2015). "Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis". Immunity. 42 (4): 756–766. doi:10.1016/j.immuni.2015.03.014. PMC 4407815. PMID 25902485.
Nakatsuji T, Chen TH, Two AM, Chun KA, Narala S, Geha RS, et al. (November 2016). "Staphylococcus aureus Exploits Epidermal Barrier Defects in Atopic Dermatitis to Trigger Cytokine Expression". The Journal of Investigative Dermatology. 136 (11): 2192–2200. doi:10.1016/j.jid.2016.05.127. PMC 5103312. PMID 27381887.
George SM, Karanovic S, Harrison DA, Rani A, Birnie AJ, Bath-Hextall FJ, et al. (October 2019). "Interventions to reduce Staphylococcus aureus in the management of eczema". The Cochrane Database of Systematic Reviews. 2019 (10). doi:10.1002/14651858.CD003871.pub3. PMC 6818407. PMID 31684694.
Rasmussen RV, Fowler VG, Skov R, Bruun NE (January 2011). "Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA". Future Microbiology. 6 (1): 43–56. doi:10.2217/fmb.10.155. PMC 3031962. PMID 21162635.
Latha T, Anil B, Manjunatha H, Chiranjay M, Elsa D, Baby N, et al. (March 2019). "MRSA: the leading pathogen of orthopedic infection in a tertiary care hospital, South India". Afr Health Sci. 19 (1): 1393–1401. doi:10.4314/ahs.v19i1.12. PMC 6531934. PMID 31148966.
Zago CE, Silva S, Sanitá PV, Barbugli PA, Dias CM, Lordello VB, et al. (2015). "Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA)". PLOS ONE. 10 (4): e0123206. Bibcode:2015PLoSO..1023206Z. doi:10.1371/journal.pone.0123206. PMC 4395328. PMID 25875834.
Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME (1 September 2011). "Staphylococcus aureus biofilms: properties, regulation, and roles in human disease". Virulence. 2 (5): 445–459. doi:10.4161/viru.2.5.17724. PMC 3322633. PMID 21921685.
Boost MV, O'Donoghue MM, James A (July 2008). "Prevalence of Staphylococcus aureus carriage among dogs and their owners". Epidemiology and Infection. 136 (7): 953–964. doi:10.1017/S0950268807009326. PMC 2870875. PMID 17678561.
Hanselman BA, Kruth SA, Rousseau J, Weese JS (September 2009). "Coagulase positive staphylococcal colonization of humans and their household pets". The Canadian Veterinary Journal. 50 (9): 954–8. PMC 2726022. PMID 19949556.
Burton S, Reid-Smith R, McClure JT, Weese JS (August 2008). "Staphylococcus aureus colonization in healthy horses in Atlantic Canada". The Canadian Veterinary Journal. 49 (8): 797–9. PMC 2465786. PMID 18978975.
Boost MV, O'Donoghue MM, James A (July 2008). "Prevalence of Staphylococcus aureus carriage among dogs and their owners". Epidemiology and Infection. 136 (7): 953–964. doi:10.1017/s0950268807009326. hdl:10397/7558. PMC 2870875. PMID 17678561.
Cheung GY, Bae JS, Otto M (December 2021). "Pathogenicity and virulence of Staphylococcus aureus". Virulence. 12 (1): 547–569. doi:10.1080/21505594.2021.1878688. PMC 7872022. PMID 33522395.
Berends ET, Horswill AR, Haste NM, Monestier M, Nizet V, von Köckritz-Blickwede M (2010). "Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps". Journal of Innate Immunity. 2 (6): 576–586. doi:10.1159/000319909. PMC 2982853. PMID 20829609.
Monteith AJ, Miller JM, Maxwell CN, Chazin WJ, Skaar EP (September 2021). "Neutrophil extracellular traps enhance macrophage killing of bacterial pathogens". Science Advances. 7 (37): eabj2101. Bibcode:2021SciA....7.2101M. doi:10.1126/sciadv.abj2101. PMC 8442908. PMID 34516771.
Dinges MM, Orwin PM, Schlievert PM (January 2000). "Exotoxins of Staphylococcus aureus". Clinical Microbiology Reviews. 13 (1): 16–34, table of contents. doi:10.1128/cmr.13.1.16. PMC 88931. PMID 10627489.
Etter D, Schelin J, Schuppler M, Johler S (September 2020). "Staphylococcal Enterotoxin C-An Update on SEC Variants, Their Structure and Properties, and Their Role in Foodborne Intoxications". Toxins. 12 (9): 584. doi:10.3390/toxins12090584. PMC 7551944. PMID 32927913.
Becker K, Friedrich AW, Lubritz G, Weilert M, Peters G, Von Eiff C (April 2003). "Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens". Journal of Clinical Microbiology. 41 (4): 1434–9. doi:10.1128/jcm.41.4.1434-1439.2003. PMC 153929. PMID 12682126.
Cao Z, Casabona MG, Kneuper H, Chalmers JD, Palmer T (October 2016). "The type VII secretion system of Staphylococcus aureus secretes a nuclease toxin that targets competitor bacteria". Nature Microbiology. 2 (1): 16183. doi:10.1038/nmicrobiol.2016.183. PMC 5325307. PMID 27723728.
Ulhuq FR, Gomes MC, Duggan GM, Guo M, Mendonca C, Buchanan G, et al. (August 2020). "A membrane-depolarizing toxin substrate of the Staphylococcus aureus type VII secretion system mediates intraspecies competition". Proceedings of the National Academy of Sciences of the United States of America. 117 (34): 20836–47. Bibcode:2020PNAS..11720836U. doi:10.1073/pnas.2006110117. PMC 7456083. PMID 32769205.
Burts ML, Williams WA, DeBord K, Missiakas DM (January 2005). "EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections". Proceedings of the National Academy of Sciences of the United States of America. 102 (4): 1169–74. Bibcode:2005PNAS..102.1169B. doi:10.1073/pnas.0405620102. PMC 545836. PMID 15657139.
Dai Y, Wang Y, Liu Q, Gao Q, Lu H, Meng H, et al. (5 May 2017). "A Novel ESAT-6 Secretion System-Secreted Protein EsxX of Community-Associated Staphylococcus aureus Lineage ST398 Contributes to Immune Evasion and Virulence". Frontiers in Microbiology. 8: 819. doi:10.3389/fmicb.2017.00819. PMC 5418362. PMID 28529509.
Kim S, Reyes D, Beaume M, Francois P, Cheung A (October 2014). "Contribution of teg49 small RNA in the 5' upstream transcriptional region of sarA to virulence in Staphylococcus aureus". Infection and Immunity. 82 (10): 4369–79. doi:10.1128/iai.02002-14. PMC 4187880. PMID 25092913.
Chevalier C, Boisset S, Romilly C, Masquida B, Fechter P, Geissmann T, et al. (March 2010). "Staphylococcus aureus RNAIII binds to two distant regions of coa mRNA to arrest translation and promote mRNA degradation". PLOS Pathogens. 6 (3): e1000809. doi:10.1371/journal.ppat.1000809. PMC 2837412. PMID 20300607.
Chabelskaya S, Gaillot O, Felden B (June 2010). "A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule". PLOS Pathogens. 6 (6): e1000927. doi:10.1371/journal.ppat.1000927. PMC 2880579. PMID 20532214.
Le Pabic H, Germain-Amiot N, Bordeau V, Felden B (October 2015). "A bacterial regulatory RNA attenuates virulence, spread and human host cell phagocytosis". Nucleic Acids Research. 43 (19): 9232–48. doi:10.1093/nar/gkv783. PMC 4627067. PMID 26240382.
Mauro T, Rouillon A, Felden B (December 2016). "Insights into the regulation of small RNA expression: SarA represses the expression of two sRNAs in Staphylococcus aureus". Nucleic Acids Research. 44 (21): 10186–200. doi:10.1093/nar/gkw777. PMC 5137438. PMID 27596601.
Bohn C, Rigoulay C, Chabelskaya S, Sharma CM, Marchais A, Skorski P, et al. (October 2010). "Experimental discovery of small RNAs in Staphylococcus aureus reveals a riboregulator of central metabolism". Nucleic Acids Research. 38 (19): 6620–36. doi:10.1093/nar/gkq462. PMC 2965222. PMID 20511587.
Morrison JM, Miller EW, Benson MA, Alonzo F, Yoong P, Torres VJ, et al. (June 2012). "Characterization of SSR42, a novel virulence factor regulatory RNA that contributes to the pathogenesis of a Staphylococcus aureus USA300 representative". Journal of Bacteriology. 194 (11): 2924–38. doi:10.1128/JB.06708-11. PMC 3370614. PMID 22493015.
Coronel-Tellez RH, Pospiech M, Barrault M, Liu W, Bordeau V, Vasnier C, et al. (August 2022). "sRNA-controlled iron sparing response in Staphylococci". Nucleic Acids Research. 50 (15): 8529–8546. doi:10.1093/nar/gkac648. PMC 9410917. PMID 35904807.
Ha KP, Clarke RS, Kim GL, Brittan JL, Rowley JE, Mavridou DA, et al. (November 2020). "Staphylococcal DNA Repair Is Required for Infection". mBio. 11 (6): e02288-20. doi:10.1128/mBio.02288-20. PMC 7683395. PMID 33203752.
Ruiz de los Mozos I, Vergara-Irigaray M, Segura V, Villanueva M, Bitarte N, Saramago M, et al. (2013). "Base pairing interaction between 5'- and 3'-UTRs controls icaR mRNA translation in Staphylococcus aureus". PLOS Genetics. 9 (12): e1004001. doi:10.1371/journal.pgen.1004001. PMC 3868564. PMID 24367275.
Nassar R, Hachim M, Nassar M, Kaklamanos EG, Jamal M, Williams D, et al. (2021). "Microbial Metabolic Genes Crucial for S. aureus Biofilms: An Insight From Re-analysis of Publicly Available Microarray Datasets". Frontiers in Microbiology. 11: 607002. doi:10.3389/fmicb.2020.607002. PMC 7876462. PMID 33584569.
Patel AH, Nowlan P, Weavers ED, Foster T (December 1987). "Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement". Infection and Immunity. 55 (12): 3103–10. doi:10.1128/IAI.55.12.3103-3110.1987. PMC 260034. PMID 3679545.
Clauditz A, Resch A, Wieland KP, Peschel A, Götz F (August 2006). "Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress". Infection and Immunity. 74 (8): 4950–3. doi:10.1128/IAI.00204-06. PMC 1539600. PMID 16861688.
Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, et al. (July 2005). "Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity". The Journal of Experimental Medicine. 202 (2): 209–215. doi:10.1084/jem.20050846. PMC 2213009. PMID 16009720.
Liu CI, Liu GY, Song Y, Yin F, Hensler ME, Jeng WY, et al. (March 2008). "A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence". Science. 319 (5868): 1391–4. Bibcode:2008Sci...319.1391L. doi:10.1126/science.1153018. PMC 2747771. PMID 18276850.
Loi VV, Busche T, Schnaufer F, Kalinowski J, Antelmann H (2023). "The neutrophil oxidant hypothiocyanous acid causes a thiol-specific stress response and an oxidative shift of the bacillithiol redox potential in Staphylococcus aureus". Microbiology Spectrum. 11 (6): e03252-23. doi:10.1128/spectrum.03252-23. PMC 10715087. PMID 37930020.
Shearer HL, Pace PE, Paton JC, Hampton MB, Dickerhof N (2022). "A newly identified flavoprotein disulfide reductase Har protects Streptococcus pneumoniae against hypothiocyanous acid". Journal of Biological Chemistry. 298 (9): 102359. doi:10.1016/J.JBC.2022.102359. PMC 9483559. PMID 35952759.
Aires de Sousa M, Conceição T, Simas C, de Lencastre H (October 2005). "Comparison of genetic backgrounds of methicillin-resistant and -susceptible Staphylococcus aureus isolates from Portuguese hospitals and the community". Journal of Clinical Microbiology. 43 (10): 5150–7. doi:10.1128/JCM.43.10.5150-5157.2005. PMC 1248511. PMID 16207977.
Thwaites GE, Scarborough M, Szubert A, Nsutebu E, Tilley R, Greig J, et al. (February 2018). "Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial". Lancet. 391 (10121): 668–678. doi:10.1016/S0140-6736(17)32456-X. PMC 5820409. PMID 29249276.
Chambers HF (2001). "The changing epidemiology of Staphylococcus aureus?". Emerging Infectious Diseases. 7 (2): 178–182. doi:10.3201/eid0702.010204. PMC 2631711. PMID 11294701.
Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. (Antimicrobial Resistance Collaborators) (February 2022). "Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis". Lancet. 399 (10325): 629–655. doi:10.1016/S0140-6736(21)02724-0. PMC 8841637. PMID 35065702.
Korotetskiy IS, Shilov SV, Kuznetsova TV, Zubenko N, Ivanova L, Reva ON (2025). "Epigenetic background of lineage-specific gene expression landscapes of four Staphylococcus aureus hospital isolates". PLOS ONE. 20 (5): e0322006. Bibcode:2025PLoSO..2022006K. doi:10.1371/journal.pone.0322006. PMC 12052166. PMID 40323905.
Jamrozy D, Coll F, Mather AE, Harris SR, Harrison EM, MacGowan A, et al. (September 2017). "Evolution of mobile genetic element composition in an epidemic methicillin-resistant Staphylococcus aureus: temporal changes correlated with frequent loss and gain events". BMC Genomics. 18 (1): 684. doi:10.1186/s12864-017-4065-z. PMC 5584012. PMID 28870171.
Pozzi C, Waters EM, Rudkin JK, Schaeffer CR, Lohan AJ, Tong P, et al. (5 April 2012). Sullam PM (ed.). "Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections". PLOS Pathogens. 8 (4): e1002626. doi:10.1371/journal.ppat.1002626. PMC 3320603. PMID 22496652.
Arthur M, Courvalin P (August 1993). "Genetics and mechanisms of glycopeptide resistance in enterococci". Antimicrobial Agents and Chemotherapy. 37 (8). ASM: 1563–71. doi:10.1128/AAC.37.8.1563. PMC 188020. PMID 8215264.
Rolinson GN, Stevens S, Batchelor FR, Wood JC, Chain EB (September 1960). "Bacteriological studies on a new penicillin-BRL. 1241". Lancet. 2 (7150): 564–7. doi:10.1136/bmj.1.5219.124-a. PMC 1952878. PMID 14438510.
Yang SJ, Bayer AS, Mishra NN, Meehl M, Ledala N, Yeaman MR, et al. (22 December 2012). "The Staphylococcus aureus Two-Component Regulatory System, GraRS, Senses and Confers Resistance to Selected Cationic Antimicrobial Peptides". Infection and Immunity. 80 (1): 74–81. doi:10.1128/iai.05669-11. PMC 3255649. PMID 21986630.
Ledger EV, Mesnage S, Edwards AM (19 April 2022). "Human serum triggers antibiotic tolerance in Staphylococcus aureus". Nature Communications. 13 (1): 2041. Bibcode:2022NatCo..13.2041L. doi:10.1038/s41467-022-29717-3. ISSN 2041-1723. PMC 9018823. PMID 35440121.
Quinn GA, Cole AM (September 2007). "Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium". Immunology. 122 (1): 80–89. doi:10.1111/j.1365-2567.2007.02615.x. PMC 2265977. PMID 17472720.
Munir MT, Pailhories H, Eveillard M, Irle M, Aviat F, Federighi M, et al. (August 2020). "Experimental Parameters Influence the Observed Antimicrobial Response of Oak Wood (Quercus petraea)". Antibiotics. 9 (9): 535. doi:10.3390/antibiotics9090535. PMC 7558063. PMID 32847132.
Neely AN, Maley MP (February 2000). "Survival of enterococci and staphylococci on hospital fabrics and plastic". Journal of Clinical Microbiology. 38 (2): 724–6. doi:10.1128/JCM.38.2.724-726.2000. PMC 86187. PMID 10655374.
van Rijen M, Bonten M, Wenzel R, Kluytmans J, et al. (Cochrane Wounds Group) (October 2008). "Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers". The Cochrane Database of Systematic Reviews. 2011 (4): CD006216. doi:10.1002/14651858.CD006216.pub2. PMC 8988859. PMID 18843708.
Liu Z, Norman G, Iheozor-Ejiofor Z, Wong JK, Crosbie EJ, Wilson P, et al. (Cochrane Wounds Group) (May 2017). "Nasal decontamination for the prevention of surgical site infection in Staphylococcus aureus carriers". The Cochrane Database of Systematic Reviews. 5 (8): CD012462. doi:10.1002/14651858.CD012462.pub2. PMC 6481881. PMID 28516472.
Torre A, Bacconi M, Sammicheli C, Galletti B, Laera D, Fontana MR, et al. (August 2015). "Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice". Infection and Immunity. 83 (8): 3157–63. doi:10.1128/IAI.00258-15. PMC 4496606. PMID 26015481.
Scheper H, Wubbolts JM, Verhagen JA, de Visser AW, van der Wal RJ, Visser LG, et al. (29 January 2021). "SAAP-148 Eradicates MRSA Persisters Within Mature Biofilm Models Simulating Prosthetic Joint Infection". Frontiers in Microbiology. 12: 625952. doi:10.3389/fmicb.2021.625952. PMC 7879538. PMID 33584628.
van den Biggelaar RH, Walburg KV, van den Eeden SJ, van Doorn CL, Meiler E, de Ries AS, et al. (2024). "Identification of kinase modulators as host-directed therapeutics against intracellular methicillin-resistant Staphylococcus aureus". Frontiers in Cellular and Infection Microbiology. 14: 1367938. doi:10.3389/fcimb.2024.1367938. PMC 10999543. PMID 38590439.

nlm.nih.gov

"Staphylococcal Infections". MedlinePlus [Internet]. Bethesda, MD: National Library of Medicine, US. Skin infections are the most common. They can look like pimples or boils.

www3.niaid.nih.gov

Bowersox J (27 May 1999). "Experimental Staph Vaccine Broadly Protective in Animal Studies". NIH. Archived from the original on 5 May 2007. Retrieved 28 July 2007.

nihr.ac.uk

evidence.nihr.ac.uk

Eczema in children: uncertainties addressed (Report). NIHR Evidence. 19 March 2024. doi:10.3310/nihrevidence_62438.

nitag-resource.org

"Status of vaccine research and development of vaccines for Staphylococcus aureus" (PDF). Elsevier. 19 April 2016. Archived (PDF) from the original on 11 October 2016. Retrieved 10 October 2016.

oup.com

academic.oup.com

Roberts RR, Hota B, Ahmad I, Scott R. Douglas, II, Foster SD, Abbasi F, et al. (15 October 2009). "Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship". Clinical Infectious Diseases. 49 (8): 1175–1184. doi:10.1086/605630. ISSN 1058-4838. PMID 19739972.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (1 January 2003). "Comparison of Mortality Associated with Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Meta-analysis". Clinical Infectious Diseases. 36 (1): 53–59. doi:10.1086/345476. ISSN 1058-4838.

oxforddictionaries.com

"staphylococcus – definition of staphylococcus in English from the Oxford dictionary". OxfordDictionaries.com. Archived from the original on 18 August 2012. Retrieved 20 January 2016. "aureus – definition of aureus in English from the Oxford dictionary". OxfordDictionaries.com. Archived from the original on 16 July 2012. Retrieved 20 January 2016.

pfizer.com

"Pfizer Begins Phase 2b Study of Its Investigational Multi-antigen Staphylococcus aureus Vaccine in Adults Undergoing Elective Spinal Fusion Surgery". Pfizer Inc. 7 July 2015. Retrieved 24 February 2016.

pubmlst.org

"S. aureus clonal complex designation". PubMLST. Retrieved 28 February 2024.

reannecy.org

Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. (March 2002). "Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients". Lancet. 359 (9308): 753–9. doi:10.1016/S0140-6736(02)07877-7. PMID 11888586. S2CID 20400336. As PDF Archived 14 July 2014 at the Wayback Machine

rff.org

"A Shot Against MRSA?" (PDF). Resources for the Future. 20 April 2009. Archived (PDF) from the original on 8 March 2016. Retrieved 7 October 2015.

semanticscholar.org

api.semanticscholar.org

Fagerlund A, Granum PE, Håvarstein LS (November 2014). "Staphylococcus aureus competence genes: mapping of the SigH, ComK1 and ComK2 regulons by transcriptome sequencing". Molecular Microbiology. 94 (3): 557–579. doi:10.1111/mmi.12767. PMID 25155269. S2CID 1568023.
Monnot GC, Wegrecki M, Cheng TY, Chen YL, Sallee BN, Chakravarthy R, et al. (January 2023). "Staphylococcal phosphatidylglycerol antigens activate human T cells via CD1a". Nature Immunology. 24 (1): 110–122. doi:10.1038/s41590-022-01375-z. PMC 10389259. PMID 35265979. S2CID 255039948.
Curran JP, Al-Salihi FL (August 1980). "Neonatal staphylococcal scalded skin syndrome: massive outbreak due to an unusual phage type". Pediatrics. 66 (2): 285–290. doi:10.1542/peds.66.2.285. PMID 6447271. S2CID 21783186.
Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. (March 2002). "Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients". Lancet. 359 (9308): 753–9. doi:10.1016/S0140-6736(02)07877-7. PMID 11888586. S2CID 20400336. As PDF Archived 14 July 2014 at the Wayback Machine
Bowman L, Palmer T (October 2021). "The Type VII Secretion System of Staphylococcus". Annual Review of Microbiology. 75 (1): 471–494. doi:10.1146/annurev-micro-012721-123600. PMID 34343022. S2CID 236915377.
Sayed N, Jousselin A, Felden B (December 2011). "A cis-antisense RNA acts in trans in Staphylococcus aureus to control translation of a human cytolytic peptide" (PDF). Nature Structural & Molecular Biology. 19 (1): 105–112. doi:10.1038/nsmb.2193. PMID 22198463. S2CID 8217681.
Xue T, Zhang X, Sun H, Sun B (February 2014). "ArtR, a novel sRNA of Staphylococcus aureus, regulates α-toxin expression by targeting the 5' UTR of sarT mRNA". Medical Microbiology and Immunology. 203 (1): 1–12. doi:10.1007/s00430-013-0307-0. PMID 23955428. S2CID 18371872.
Bonomo RA, Van Zile PS, Li Q, Shermock KM, McCormick WG, Kohut B (October 2007). "Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspective". Expert Review of Anti-Infective Therapy. 5 (5): 773–782. doi:10.1586/14787210.5.5.773. PMID 17914912. S2CID 31594289.
Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V (September 2000). "Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics". Nature. 407 (6802): 340–8. Bibcode:2000Natur.407..340C. doi:10.1038/35030019. PMID 11014183. S2CID 4408938.
Chen CJ, Huang YC (August 2018). "Emergence of livestock-associated methicillin-resistant Staphylococcus aureus: Should it be a concern?". Journal of the Formosan Medical Association = Taiwan Yi Zhi. 117 (8): 658–661. doi:10.1016/j.jfma.2018.04.004. PMID 29754805. S2CID 21659477.
Campos A, Arias A, Betancor L, Rodríguez C, Hernández AM, López Aguado D, et al. (July 1998). "Study of common aerobic flora of human cerumen". The Journal of Laryngology and Otology. 112 (7): 613–6. doi:10.1017/s002221510014126x. PMID 9775288. S2CID 29362695.
Bolton KJ, Dodd CE, Mead GC, Waites WM (1988). "Chlorine resistance of strains of Staphylococcus aureus isolated from poultry processing plants". Letters in Applied Microbiology. 6 (2): 31–34. doi:10.1111/j.1472-765X.1988.tb01208.x. S2CID 84137649.
Mead GC, Adams BW (1986). "Chlorine resistance of Staphylococcus aureus isolated from turkeys and turkey products". Letters in Applied Microbiology. 3 (6): 131–3. doi:10.1111/j.1472-765X.1986.tb01566.x. S2CID 86676949.

thepoultrysite.com

"Staphylococcosis, Staphylococcal Arthritis, Bumble Foot". The Poultry Site. Retrieved 22 October 2013.

web.archive.org

Bowersox J (27 May 1999). "Experimental Staph Vaccine Broadly Protective in Animal Studies". NIH. Archived from the original on 5 May 2007. Retrieved 28 July 2007.
"staphylococcus – definition of staphylococcus in English from the Oxford dictionary". OxfordDictionaries.com. Archived from the original on 18 August 2012. Retrieved 20 January 2016. "aureus – definition of aureus in English from the Oxford dictionary". OxfordDictionaries.com. Archived from the original on 16 July 2012. Retrieved 20 January 2016.
"Staphylococcus aureus in Healthcare Settings". www.cdc.gov. 10 December 2020. Archived from the original on 15 May 2024. Retrieved 28 April 2025.
Woodson J. "Centers for disease control and prevention". Food Safety. Archived from the original on 8 February 2016. Retrieved 24 October 2017.
Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. (March 2002). "Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients". Lancet. 359 (9308): 753–9. doi:10.1016/S0140-6736(02)07877-7. PMID 11888586. S2CID 20400336. As PDF Archived 14 July 2014 at the Wayback Machine
"Recommendations for Preventing the Spread of Vancomycin Resistance Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)". CDC. 22 September 1995. Archived from the original on 23 September 2006.
Shafiei Y, Razavilar V, Javadi A (2011). "Thermal Death Time of Staphylococcus Aureus (PTCC=29213) and Staphylococcus Epidermidis (PTCC=1435) in Distilled Water" (PDF). Australian Journal of Basic and Applied Sciences. 5 (11): 1551–4. Archived (PDF) from the original on 2 July 2015.
"A Shot Against MRSA?" (PDF). Resources for the Future. 20 April 2009. Archived (PDF) from the original on 8 March 2016. Retrieved 7 October 2015.
"Strengthening the immune system as an antimicrobial strategy against Staphylococcus aureus infections" (PDF). FORMATEX RESEARCH CENTER. 11 December 2013. Archived (PDF) from the original on 22 November 2015. Retrieved 7 October 2015.
"Vaccines to prevent antibiotic-resistant Staphylococcus aureus (MRSA)infections" (PDF). University of Chicago. Archived (PDF) from the original on 10 September 2016. Retrieved 11 May 2017.
"Status of vaccine research and development of vaccines for Staphylococcus aureus" (PDF). Elsevier. 19 April 2016. Archived (PDF) from the original on 11 October 2016. Retrieved 10 October 2016.

who.int

"Vaccines to prevent antibiotic-resistant Staphylococcus aureus (MRSA)infections" (PDF). University of Chicago. Archived (PDF) from the original on 10 September 2016. Retrieved 11 May 2017.

worldcat.org

search.worldcat.org

Roberts RR, Hota B, Ahmad I, Scott R. Douglas, II, Foster SD, Abbasi F, et al. (15 October 2009). "Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship". Clinical Infectious Diseases. 49 (8): 1175–1184. doi:10.1086/605630. ISSN 1058-4838. PMID 19739972.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. (17 October 2007). "Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States". JAMA. 298 (15): 1763–1771. doi:10.1001/jama.298.15.1763. ISSN 0098-7484. PMID 17940231.
Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. (9 December 2013). "Health Care–Associated Infections: A Meta-analysis of Costs and Financial Impact on the US Health Care System". JAMA Internal Medicine. 173 (22): 2039–2046. doi:10.1001/jamainternmed.2013.9763. ISSN 2168-6106. PMID 23999949.
Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. (May 2010). "Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)". Infection Control & Hospital Epidemiology. 31 (5): 431–455. doi:10.1086/651706. ISSN 0899-823X. PMID 20307191.
Kourtis AP (2019). "Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States". MMWR. Morbidity and Mortality Weekly Report. 68 (9): 214–219. doi:10.15585/mmwr.mm6809e1. ISSN 0149-2195. PMC 6421967. PMID 30845118.
Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (1 January 2003). "Comparison of Mortality Associated with Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Meta-analysis". Clinical Infectious Diseases. 36 (1): 53–59. doi:10.1086/345476. ISSN 1058-4838.
Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, et al. (25 November 2013). "National Burden of Invasive Methicillin-Resistant Staphylococcus aureus Infections, United States, 2011". JAMA Internal Medicine. 173 (21): 1970–1978. doi:10.1001/jamainternmed.2013.10423. ISSN 2168-6106. PMC 10887428. PMID 24043270.
Pader V, Hakim S, Painter KL, Wigneshweraraj S, Clarke TB, Edwards AM (24 October 2016). "Staphylococcus aureus inactivates daptomycin by releasing membrane phospholipids". Nature Microbiology. 2 (1): 16194. doi:10.1038/nmicrobiol.2016.194. hdl:10044/1/40119. ISSN 2058-5276. PMID 27775684.
Ledger EV, Mesnage S, Edwards AM (19 April 2022). "Human serum triggers antibiotic tolerance in Staphylococcus aureus". Nature Communications. 13 (1): 2041. Bibcode:2022NatCo..13.2041L. doi:10.1038/s41467-022-29717-3. ISSN 2041-1723. PMC 9018823. PMID 35440121.